Patent Grant
11471210
Various embodiments of the invention pertain generally to methods and systems for therapeutic treatment of pain, and more particularly to therapeutic treatment of back pain.
Body pain may originate in muscles, organs, bones, or other areas of the body. One example of body pain is back pain, or pain associated with the spine. Back pain is a huge health problem worldwide and is the cause of much human suffering. Back pain is also a major cause for work-related disability benefits and compensation. Treatments for back pain vary widely, ranging from physical therapy, to pharmacological therapy and pain management, to surgical intervention.
Use of pharmaceuticals to treat back pain has at least three concerns. First, the patient may become dependent upon the pharmaceuticals. Second, the cost of the pharmaceuticals, usually over several years, may be extremely costly. Third, generally, the pain persists over many years.
Surgery also presents several concerns. First, most techniques involve fusing the vertebrae of the spine together and/or removing tissue from between the vertebrae. While surgery usually provides long-term relief, e.g., greater than one-year, surgical techniques require extensive recovery time and additional physical therapy for the patient.
While physical therapy does not present all of the concerns of surgery or using pharmaceuticals, patients receive varying degrees of relief from pain. Additionally, physical therapy usually provides only short-term pain relief, e.g., one to two months, thereby extending treatment over several years, and thus increasing the cost of treatment. Moreover, 1 many patients ultimately require surgery.
Several embodiments of the invention are directed to a method for treating back pain associated with a vertebral body of a patient, wherein the vertebral body is innervated by a basivertebral nerve having an origin at a medial branch of a sinuvertebral nerve and that courses medially under the posterior longitudinal ligament to enter the vertebral body at a basivertebral foramen of the vertebral body. In some embodiments, the method comprises identifying at least a portion of a basivertebral nerve associated with the vertebral body and isolating the basivertebral nerve at a location external to the vertebral body. In some embodiments, the method comprises modulating (e.g., denervating, temporarily or permanently blocking nerve conduction, altering a conductive property, stimulating, severing, cutting, crimping, heating, cooling, radiating, agitating, or altering the chemical composition of) the basivertebral nerve at the external location to treat pain associated with the vertebral body.
Several embodiments of the invention are directed to a method for treating back pain associated with a vertebral body of a patient. In some embodiments, the method comprises percutaneously guiding a delivery device within or near the vertebral body. In some embodiments, the method comprises identifying at least a portion of a basivertebral nerve associated with the vertebral body and isolating the basivertebral nerve at a location external to the vertebral body. In some embodiments, the method comprises delivering a treatment device to the external location using the delivery device and operating the treatment device at the external location. In some embodiments, the operation of the treatment device is configured to modulate the basivertebral nerve at the external location to treat pain associated with the vertebral body. In one embodiment, the delivery device comprises a catheter comprising a first lumen for advancing an imaging device and a second lumen for advancing the treatment device.
In some embodiments, the basivertebral nerve comprises a medial branch of a sinuvertebral nerve, wherein the basivertebral nerve emanates at a first end at a junction of the sinuvertebral nerve and wherein the basivertebral nerve courses medially from the junction under the posterior longitudinal ligament. In some embodiments, the basivertebral nerve enters the vertebral body at a second end located at a basivertebral foramen of the vertebral body. Modulation of the basivertebral nerve may be performed at a location on the basivertebral nerve at or near the second end located within the basivertebral foramen.
In some embodiments, identifying at least a portion of the basivertebral nerve comprises locating the sinuvertebral nerve and locating the junction of the basivertebral nerve with the sinuvertebral nerve. In one embodiment, modulating the basivertebral nerve comprises modulating the basivertebral nerve at a location on the basivertebral nerve at or near the junction with the sinuvertebral nerve. In one embodiment, the method comprises verifying that the basivertebral nerve courses medially under the posterior longitudinal ligament prior to modulating the basivertebral nerve. In some embodiments, the posterior longitudinal ligament is dilated to allow visualization of the basivertebral foramen prior to modulation of the basivertebral nerve.
In several embodiments, isolating the basivertebral nerve comprises following the basivertebral nerve from the junction medially under the posterior longitudinal ligament and dilating a space under the posterior longitudinal ligament to visualize the basivertebral foramen. In one embodiment, the method comprises locating the basivertebral foramen via direct visualization with an imaging device and modulating the basivertebral nerve at a location on the basivertebral nerve at or near the second end located within the basivertebral foramen.
In some embodiments, the step of modulating the basivertebral nerve comprises positioning an energy delivery device into the basivertebral foramen and directing a field of energy into the basivertebral foramen to denervate the basivertebral nerve, wherein the directed energy field is focused to be confined in a first direction into the basivertebral foramen. In some embodiments, the step of identifying at least a portion of the basivertebral nerve comprises locating the sinuvertebral nerve via direct visualization with an imaging device and locating the junction of the basivertebral nerve with the sinuvertebral nerve.
Several embodiments of the invention are directed to a system for treating back pain associated with a vertebral body of a patient. The system may comprise a delivery assembly configured to be percutaneously delivered to a treatment region adjacent the vertebral body. The delivery assembly may comprise a catheter having one or more lumens and an energy delivery device configured to be advanced within one of the catheter lumens. In some embodiments, the energy delivery device is sized to allow positioning of a distal end of the energy delivery device at a treatment region (such as the origin of the basivertebral nerve with the sinuvertebral nerve, or into the basivertebral foramen). In one embodiment, the energy delivery device comprises an energy delivery element configured to direct a focused field of energy (e.g., for focusing energy into the basivertebral foramen to modulate the basivertebral nerve) such that the directed energy field is focused to be confined in a first 3 direction into the basivertebral foramen.
In some embodiments, the energy delivery element is configured to emit therapeutic energy radially outward from the distal end of the energy delivery device while substantially shielding energy delivery toward a proximal end of the energy delivery device. In some embodiments, the delivery assembly comprises an imaging device (e.g., visualization scope or camera) to aid in visualization of the basivertebral foramen and delivery of the energy delivery device into the basivertebral foramen. In one embodiment, the delivery assembly comprises an aspirating device to be delivered under the posterior longitudinal ligament via the one ore more lumens of the catheter. The aspiration device may be configured to dilate a space under the posterior longitudinal ligament to aid in visualization of the basivertebral foramen.
Several embodiments of the invention are directed to a method for denervating a basivertebral nerve to treat back pain using an externally positioned energy source (e.g., radiation, ultrasound, microwave source). The energy source may comprise a plurality of sources. The plurality of sources may be configured to deliver different energy modalities and/or deliver energy at different times. In one embodiment, the method includes acquiring imaging data of the vertebra. In one embodiment, the method comprises determining a target treatment site within or near the vertebra based on the acquired imaging data that corresponds to a location of a basivertebral nerve associated with pain in the vertebral body. In one embodiment, the step of determining a target treatment site is performed visually without acquiring imaging data. In one embodiment, the method comprises positioning a focal point of an external energy source to substantially coincide with the target treatment site. The target treatment site may be within or outside the vertebral body. The target treatment site may correspond to a location of a basivertebral nerve associated with pain in the vertebral body. In several embodiments, the target treatment site is a location within a basivertebral foramen of the vertebral body.
In one embodiment, the external energy source is positioned at a location external to the body of a patient. In one embodiment, the method comprises delivering a treatment dose of therapeutic energy at the target treatment site, wherein the treatment dose is configured to modulate (e.g., denervate, temporarily or permanently block or eliminate nerve conduction, alter a conductive property, stimulate, heat, cool, radiate, agitate, disrupt, ablate, or alter the chemical composition of) the basivertebral nerve.
In one embodiment, the method comprises acquiring patient feedback prior to delivering the treatment dose (e.g., using one or more sensors or monitors or through 4 conversation with the patient). In one embodiment, acquiring patient feedback comprises delivering an identification dose that is a lesser dose than the treatment dose to the target treatment site and eliciting feedback from the patient with respect to a change in the sensation of pain. The identification dose may be prescribed such that the identification dose temporarily alters the sensation of pain experienced by the patient. In one embodiment, the method comprises modifying the target treatment site or location according to the acquired feedback.
Treatment may be delivered to the target treatment site to modulate at least a portion of the basivertebral nerve (e.g., terminus or junction or a portion of the basivertebral nerve between the terminus or junction and the posterior wall). In one embodiment, a portion of the basivertebral nerve is modulated by delivering focused energy (e.g., radiation, acoustic or ultrasonic energy) to an isolated region of the basivertebral nerve. In one embodiment, the focused energy is high-intensity focused ultrasonic energy. In another embodiment, a portion of the basivertebral nerve is modulated by delivering an agent to the treatment region to isolate treatment to that region. In accordance with several embodiments of the invention, the treatment is advantageously focused on a location of the basivertebral nerve that is upstream of one or more branches of the basivertebral nerve.
In some embodiments, delivering the treatment dose comprises delivering a first incremental dose that is a fraction of the treatment dose and then acquiring imaging data of the patient. The method may comprise measuring the distance between the focal point of the energy source and the target treatment site and then moving the external energy source such that the focal point of the external energy source coincides with the target treatment site if the measured distance is not within a predetermined threshold. In some embodiments, delivering the treatment does comprises delivering a second incremental dose if the measured distance is within the predetermined threshold.
Nerves within bones other than the vertebrae or spine may be targeted by the external energy source, for example, non-spinal joints or in non-orthopedic applications (e.g., cardiac, pulmonary, renal, or treatment of other organs and/or their surrounding nerves). The external energy source may comprise at least one radiation source or at least one acoustic energy source. In one embodiment, the at least one acoustic energy source comprises one or more transducers configured to deliver focused ultrasonic energy (e.g., high-intensity focused ultrasonic energy or low-intensity focused ultrasonic energy). In one embodiment, the external energy source comprises at least one microwave source.
In some embodiments, the step of determining a target treatment site 5 comprises acquiring a vertebral reference point corresponding to a radiographically identifiable anatomical feature of the vertebra and generating coordinates for the target treatment site as a function of a calculated distance from the vertebral reference point. In one embodiment, the calculated distance corresponds to a predicted basivertebral nerve location that is obtained from analysis of the acquired imaging data.
In some embodiments, the step of acquiring imaging data comprises restraining at least a portion of the patient to an external support. In one embodiment, the external support comprises a radiographically identifiable marker. Acquiring imaging data may comprise imaging the patient and locating the radiographically identifiable marker within the acquired image. The method may comprise assigning an external reference point corresponding to the location of the radiographically identifiable marker. In one embodiment, the external reference point is as a base point for positioning the focal point of the external energy source at the target treatment site. In one embodiment, the method comprises acquiring a vertebral reference point corresponding to a radiographically identifiable anatomical feature of the vertebra and generating coordinates for the target treatment site as a function of a calculated distance from the vertebral reference point. In some embodiments, the step of determining a target treatment site is performed by direct visualization without calculations based on acquired imaging data.
Several embodiments of the invention are directed to a system for treating back pain associated with the spine (e.g., one or more vertebrae) of a patient. In several embodiments, the system provides non-invasive treatment of the back pain by modulating spinal nerves (e.g., intraosseous or basivertebral nerves) from outside the body. In some embodiments, the system comprises an external energy (e.g., radiation) source configured to be positioned at a location external to the body of the patient. In one embodiment, the system comprises a linear drive configured to drive translation of the external energy source with respect to the patient in one or more axes. In one embodiment, the system comprises a computer coupled to the external energy source and to the linear drive. In one embodiment, the system comprises programming instructions executable on the computer. In several embodiments, the programming instructions comprise one or more modules for performing one or more of the following: determining a target treatment site within or near the spine (e.g., vertebral body) based on acquired imaging data or based on direct visualization; controlling the linear drive to position a focal point of the external energy source to substantially coincide with a target treatment site that corresponds to a location of a basivertebral nerve associated with pain in the spine (e.g., vertebral body); and controlling the 6 external energy source to deliver a treatment dose of therapeutic energy at the target treatment site. In several embodiments, the treatment dose is configured to modulate (e.g., denervate) the basivertebral nerve. The therapeutic system may include a treatment device and an imaging device. In one embodiment, the treatment device and the imaging device are combined into a single unitary device. The focal point may be adjusted depending on imaging obtained by the imaging device or other feedback mechanisms.
In some embodiments, the system comprises an imaging source coupled to the computer for acquiring imaging data of the spine (e.g., vertebrae or vertebral bodies). In one embodiment, the system comprises a support configured to restrain at least a portion of the patient to an external support. The support may comprise a radiographically identifiable marker. In one embodiment, the executable program instructions are configured to control the imaging source for imaging the patient, locate the radiographically identifiable marker within the acquired image; and assign an external reference point corresponding to the location of the radiographically identifiable marker. The external reference point may be used as a base point for positioning the focal point of the external energy source at the target treatment site.
In some embodiments, the system comprises a radial drive coupled to the external energy source. The radial drive may be configured to rotate the external energy source about the target treatment site during delivery of the treatment dose. The external energy source may comprise one or more radiation-emitting and/or acoustic energy sources having a common focal point or different focal points.
Several embodiments of the invention are directed to a radiotherapy method for treating back pain associated with a vertebral body of a vertebra of a patient. In one embodiment, the method comprises acquiring imaging data of the vertebra and determining a target treatment site within the vertebra based on the acquired imaging data. In one embodiment, the target treatment site corresponds to a location of a basivertebral nerve associated with pain in the vertebral body. The method may further comprise positioning a focal point of an external radiation source to substantially coincide with the target treatment site and delivering a treatment dose of therapeutic energy at the target treatment site to modulate the basivertebral nerve.
Several embodiments of the invention are directed to a radiotherapy system for treating back pain associated with a vertebral body of a patient. In some embodiments, the system comprises an external radiation source configured to be positioned at a location external to the body of the patient. In one embodiment, the system comprises a 7 linear drive coupled to the radiation source, the linear drive configured to drive translation of the radiation source in one or more axes. In some embodiments, the system comprises a computer coupled to the radiation source and to the linear drive. The computer may comprise programming instructions executable on the computer for determining a target treatment site within or near the vertebra based on acquired imaging data, wherein the target treatment site corresponds to a location of a basivertebral nerve associated with pain in the vertebral body. In one embodiment, the programming instructions are further configured to control the linear drive to position a focal point of the external energy source to substantially coincide with the target treatment site and/or to control the external radiation source to deliver a treatment dose of therapeutic energy at the target treatment site. In some embodiments, the treatment dose is configured to modulate the basivertebral nerve at the location.
Further aspects of embodiments of the invention will be discussed in the following portions of the specification. With respect to the drawings, elements from one figure may be combined with elements from the other figures.
Several embodiments of the invention will be more fully understood by reference to the following drawings which are for illustrative purposes only:
In accordance with several embodiments, back pain may be associated with one or more nerves in the spine. For example, one or more intraosseous or basivertebral nerves within one or more vertebrae of the spine may be the source of the back pain. In some embodiments, the nerves are treated (e.g., modulated) at nerve portions that are isolated outside of the bony tissue of the vertebral body (e.g., external to the vertebral body). In some embodiments, the nerves are treated from a location external to the skin (e.g., extracorporeal, non-invasive) treatment.
Identification, Isolation, and Modulation of Basivertebral Nerve
Referring to
As shown in
In accordance with several embodiments, the medial branch 30 comprises the basivertebral nerve that innervates the vertebral body 40, and is in large part responsible for back pain experienced by a subject (e.g., human or animal patient).
The basivertebral nerve 30 comprises the largest medial branch emanating from the sinuvertebral nerve 28, which runs medially under the posterior longitudinal ligament 32. The basivertebral nerve 30 travels into the basivertebral foramen 42 to innervate the vertebral body.
In a second “open” approach, the intraosseous nerves (e.g., basivertebral nerves) may be modulated during an open surgery or surgical repair of the spine 10, wherein the patient's spine, or a portion thereof, is fully exposed for the primary surgery (e.g., vertebral fracture repair, spinal fixation, tumor removal, etc.). The basivertebral nerves 30 may be permanently or temporarily denervated (e.g., ablated, cut, crimped) as a prophylactic measure against subsequent post-surgical back pain. In some embodiments, intraosseous nerve modulation (e.g., ablation, denervation, stimulation) may also occur prior to the primary spinal surgery.
Regardless of whether the basivertebral nerve modulation is performed percutaneously or as a secondary procedure during a conventional spinal surgical repair, the following discussion is directed to various embodiments of surgical methods for accessing basivertebral nerves. While the following description is limited to three different approaches for accessing the basivertebral nerves, alternative approaches may be taken by the surgeon depending upon the clinical setting without varying from the spirit and/or scope of the disclosure.
Referring back to
Referring to
Referring to
Referring back to
The goal of the treatment or modulation (e.g., denervation) may be ablation or necrosis of the target nerve or tissue, or some lesser degree of treatment to denervate the basivertebral nerve. For example, the treatment energy, frequency and/or other treatment parameters may be just sufficient to stimulate the nerve to block the nerve from transmitting signals (e.g., signals indicative of pain).
In one embodiment, the treatment system 200 (shown in
In one embodiment, the treatment device is configured to deliver therapeutic treatment that is targeted to block nerve conduction without ablating the nerve (e.g., treatment is delivered to the nerve via thermal therapy, chemical agent, or the like) that results in denervation of the basivertebral nerve without necrosis of tissue. This may be achieved via delivery of a lesser amount of energy or agent to the tissue site (either in the form of less exposure time, concentration, intensity, etc.) than is required for ablation, but an amount sufficient to achieve some amount of temporary or permanent denervation. In some embodiments, the treatment device is configured to stimulate nerves.
In one embodiment, dosing of the treatment therapy may be tailored to the desired goal for modulation, the region or type of tissue to be treated, and the modality being used, among other factors.
In one embodiment, when heating is the applied modality, a minimum dose threshold of 30 CEMs (Cumulative Equivalent Minutes), with temperatures between 40° C. and 100° C. (e.g., between about 40° C. and about 60° C., between about 40° C. and about 80° C., between about 50° C. and about 90° C., between about 60° and about 100° C., between about 50° C. and about 80° C., or overlapping ranges thereof) is applied for some tissues. In some embodiments, cooling is administered to the target tissue (using either the treatment device or a separate device.
In some embodiments, a thermal dose of 300 CEMs may be used to ablate tissues, and sometimes the dose may reach 1000 CEMs or more. The delivered dose may be a function of several different variables: e.g., tissue type, thermal conduction of the surrounding tissues, treatment region, treatment type, and other uncontrolled variables. In various embodiments, the thermal dose may be between about 30 and about 1000 CEMs, between about 100 and about 500 CEMs, between about 50 and about 300 CEMs, between about 200 and about 400 CEMs, between about 300 and about 800 CEMs, between about 400 and about 900 CEMs, between about 500 and about 1500 CEMs, or overlapping ranges thereof.
In some embodiments, such as when RF energy is used, the impedance of the target tissue may also have an effect and be factored in the desired dosing treatment plan. If ultrasound energy is used, the propagation of the energy through the tissues is a major factor, (e.g., ultrasound generally propagates better through soft tissues than hard tissues, such as bone). Propagation of the energy (e.g., via ultrasound or RF) may be also be enhanced or modified by other substances added to the local tissues. The ultrasound energy may be used for cavitation or non-cavitation.
In one embodiment, the material used to enhance the conduction of the energy may be a biological material such as blood. In some embodiments, the biological material may serve to enhance the energy delivery while simultaneously acting as an insulator for another area of the body. For example, delivery of blood may enhance the propagation of thermal energy at some temperatures, but may act as in insulator if exposed to higher temperatures, thus effectively blocking the transmission of potently damaging thermal energy to other neighboring nerves or anatomy once a threshold temperature is exceeded). In embodiments where RF energy is used for heating the nerve or other target tissue, the frequency may be any integer between about 100 kHz and 1 MHz, between 400 kHz and 600 kHz, between 300 kHz and 500 kHz, between 350 kHz and 600 kHz, between 450 kHz and 600 kHz, between 300 kHz and 450 kHz, between 350 kHz and 500 kHz, between 400 kHz and 600 kHz, between 450 kHz and 550 kHz, between 460 kHz and 500 kHz overlapping ranges thereof, or any frequency within the recited ranges.
For stimulation of the nerve using RF energy, in accordance with several embodiments, the frequency may be applied at a substantially lower level, e.g., in the range of approximately 1 Hz to 200 kHz, and may be used in a pulsed or continuous mode. In one embodiment, the total CEMs in the stimulation mode are maintained below 30 to limit tissue damage. Pulsed energy may be used to stimulate the nerve in one mode and then the frequency, pulse width or intensity may be modulated (e.g., increased) to achieve ablative/destructive doses of energy. In one embodiment, stimulation of the nerve is performed to block the travel of signals indicative of pain. Stimulation may comprise mechanical, electrical, or electromechanical stimulation.
Each vertebra generally comprises a left and right basivertebral nerve 30 that leads into the vertebral body 40. Accordingly, once a first side (e.g. left side) is treated, the procedure may then be repeated for the corresponding opposite side (e.g. right side). In some embodiments, a “side” is defined by a center line extending from the center of the posterior outer cortical wall to the center of the anterior cortical wall. In other embodiments, “side” can be defined by any line extending through the center of the vertebral body.
Patient feedback may be acquired at particular stages within the procedure. For example, in one embodiment, the target region of the basivertebral nerve 30 may be heated at a lower, non-destructive or “stimulating” level to generate a desired temporary therapeutic response from the patient. Patient feedback may then be obtained to verify that the location is correct before a destructive or permanent dose is delivered.
In some embodiments, the treatment system 200 comprises a treatment device 204 for achieving the desired denervation at the treatment location at the basivertebral nerve 30. The treatment device 204 may be configured to deliver any number of treatment modalities (singly or in combination) at the treatment site for therapeutic denervation of the basivertebral nerve 30 or other nerves within bone. For example, treatment may be affected by monopolar, bipolar or tripolar RF, ultrasound, acoustic, radiation, steam, microwave, laser, light, or other heating means. Additionally, in some embodiments, the treatment device 204 may comprise a fluid delivery catheter that deposits an agent (e.g., bone cement, chemoablative fluid, radioactive substance, or other therapeutic agent) to the treatment location at the basivertebral nerve 30. In one embodiment, cryogenic cooling may be delivered for localized treatment of the basivertebral nerve 30. In one embodiment, treatment may be affected by any mechanical destruction and or removal means capable of severing or denervating the basivertebral nerve 30. For example, a cutting blade, bur or mechanically actuated cutter may be used to affect denervation of the basivertebral nerve 30.
In accordance with several embodiments, and in addition to or separate from treating the basivertebral nerve, a sensor (not shown) may be delivered to the region to preoperatively or postoperatively measure nerve conduction or heating at the treatment region. In this configuration, the sensor may be delivered on a distal tip of a flexible probe that may or may not have treatment elements (e.g., electrodes, ultrasound transducers, microwave elements) as well.
In one embodiment, system 200 comprises a camera 208 or other imaging device sized to be received within delivery assembly 202. The camera 208 can be configured to provide visualization of the nerves and surrounding anatomy for navigating to the proper location and identification of the basivertebral nerve 30 and surrounding anatomy. The imaging device can comprise one or more optical fibers for lighting and/or one or more optical fibers for imaging.
In one embodiment, system 200 further comprises an aspiration device 206 sized to be received within delivery assembly 202 for delivering fluid to the region (e.g., under the posterior longitudinal ligament 32 to dilate a space under the posterior longitudinal ligament 32 for visualization of the basivertebral nerve 30, basivertebral foramen 42, or other anatomy). Aspiration of the surrounding anatomy may be used for navigating to the proper location and identification of the basivertebral nerve 30 and surrounding anatomy (e.g. sinuvertebral nerve, 28 and/or basivertebral foramen 42).
In one embodiment, system 200 may comprise a secondary visualization and/or imaging means 210, such as radiographic (x-ray) imaging, to be used in combination with, or in alternative to, direct imaging. For example, the basivertebral foramen 42 may be located via radiographic imaging for direct treatment of the basivertebral nerve 30 within the basivertebral foramen.
In one embodiment, catheter 202 comprises a first lumen 220 for delivery of a camera 208 or other imaging device. In some embodiments, catheter 202 comprises a second delivery lumen 222 for delivery of a treatment device 204, which may comprise a treatment element 212. Treatment element 212 may comprise an energy/therapy delivery applicator (e.g., RF element, agent delivery lumen, cutting blade, or the like) for treatment of the basivertebral nerve 30 at the treatment location. In one embodiment, catheter 202 comprises a third lumen 224 for delivery of an aspiration device 206 simultaneously with either the imaging device 208 or treatment device 204.
As explained above, the treatment location may comprise the location of the basivertebral nerve 30 at the entry point within the vertebral body 40 within the basivertebral foramen 42.
In one embodiment, once the first basivertebral nerve 30 is treated within the first basivertebral foramen 42, the treatment device 204 may then be disposed in the other basivertebral foramen 42 to treat the basivertebral nerve 30 on the other side. This may be achieved by advancing treatment assembly 202 further within the canal 46, or by accessing the other basivertebral foramen 42 from the opposite side of the vertebra 12.
In one embodiment, the basivertebral foramen 42 is accessed through a transpedicular approach, where a channel (shown as dashed lines in
As seen in
Cadaver Study of the Proximal Basivertebral Neuroanatomy
The following study was performed on the neuroanatomy of the proximal basivertebral system, with the specific objective of identifying neural components entering the basivertebral foramina, and tracing the primary basivertebral nerve to a point of origin. A series of three cadaver studies were conducted to identify the origination of the basivertebral nerve and path into the vertebral body. The three cadaver studies are non-limiting examples of embodiments of identification of basivertebral nerve origin.
Cadaver Dissection I (Cadaver A)
With the cadaver in the prone position, a midline incision was made over the lumbar spine from L2 to S1 and extended laterally 10 cm at each end into an ‘H’. The paraspinal muscles and other soft tissues were elevated and dissected clear of the posterior spine with sharp dissection, and the lamina exposed. The dorsal spine and lamina were totally excised utilizing an oscillating saw, exposing the spinal canal and cord (within the dura) and the dorsal ganglia.
The cord was gently retracted with dural retractors, ligatures placed for traction, and the Posterior Lateral Ligament isolated and gently elevated clear of the posterior spinal canal with blunt dissection technique.
The adherent elements of soft tissue were gently cleared by blunt dissection using alternating saline saturated and dry gauze sponges, exposing elements of the neural network and the basivertebral foramina. Further local dissection at each foramen was conducted to provide visibility for specific appreciation of the various elements entering the foramina.
Referring to
Cadaver Dissection II (Cadaver B)
With the cadaver in the prone position, a midline incision was created overlying the Lumbar spine approximately 20 cm in length. Sharp dissection was used to expose the posterior aspect of the lumbar spinous processes. With these landmarks well exposed, the incision was extended laterally approximately 5 cm in each direction at both ends of the original incision to create a very wide exposure (in the shape of an “H”). Following this, the lamina and facet joints of L1, L2, L3, and L4, were widely exposed. Rongeurs and osteotomes were then used to remove the facet joints, lamina, and ligamentum flavum creating a wide exposure of the dura, the Dorsal Root Ganglion, and exiting nerve roots. Pedicles were divided on the coronal plane.
Beginning on the left side, the nerve roots were divided as they exited the central dural sac. The central dura thus drained of CSF, collapsed and was gently retracted medially out of the field. The root itself was then gently retracted laterally. With careful elevation of the nerve root, the sinuvertebral nerve was easily identified at each of the levels dissected, as it branched off of the large nerve root and coursed back through the foramen (between the remaining stumps of the pedicles).
Results
The sinuvertebral nerve divided variably into 3 or more branches, as expected. In every case, however, a branch of the sinuvertebral nerve was seen to course medially beneath the posterior longitudinal ligament. The posterior longitudinal ligament in this cadaver was very white and somewhat flaccid, and the space beneath it could be well visualized by only partially dividing it. Referring to
Having successfully established the basivertebral nerve's origin as a branch of the sinuvertebral nerve and having mapped the basivertebral nerve's usual course, additional detailed dissections were undertaken to further document and illuminate these findings and to gain some understanding of the nature and prevalence of individual variants.
Cadaver Dissection III
Cadavers were positioned prone on a dissecting table. A longitudinal midline incision was made from L1 to the mid sacral level. The skin, subcutaneous fat was divided to expose the lumbar fascia. The fascial incision was carried out, also longitudinally, and the paraspinal muscles were dissected off of the spinous processes and the lamina bilaterally. The skin incision was then extended laterally from the proximal and distal end, approximately 8 cm on both sides to create the shape of an H.
These large flaps were then developed on both sides to allow good exposure of the spinous processes, lamina, facet joints and interlaminal spaces from L5 to L1.
Spinous processes were removed with rib cutters, and the lumbar lamina then removed with rongeurs and Cloward type punches. Blunt dissection allowed exposure of the dural sac. The facet joints were then completely removed bilaterally using osteotomes and rongeurs to expose the pedicle, which was viewable “end on” transected in the coronal plane. Exiting nerve roots were identified, and exposed from the axilla, to at least one cm beyond the lateral border of the pedicle, and beyond the thickened portion of the dorsal root ganglion. Following the gross exposure, superior visualization surgical loupes (3.5×) were used for visualization of the finer neurovascular structures during the remainder of the dissection.
Exposure of the sinuvertebral nerve was accomplished by transecting the nerve root at its base as it branched off of the dural sac. The root was then carefully and gently reflected laterally and the volar aspect inspected. In all cases, the sinuvertebral nerve was seen to exit the volar aspect of the sheath, at or immediately lateral to the distal portion of the ganglion. In many cases, other small nerves were also seen to emerge immediately distal to the dorsal root ganglion, sometimes (but not always) anastamosing with the sinuvertebral nerve. Most of the other small nerves coursed dorsally or posteriorly. Generally, only one nerve (the sinuvertebral nerve) coursed retrograde back through the foramen.
The details of the anatomy at each exposed level are described below:
Cadaver C
L5 left: The sinuvertebral nerve entered the epidural space before the first small branch was noted, which coursed directly caudad. The larger branch coursed cephalad to the level of the inferior border of the L5 pedicle, when a large branch travelled medially, directly to the basivertebral foramen
L5 Right: Two branches were seen to arise from the root, just past the thickening of the ganglion. The smaller branch coursed inferomedially before branching into two equally sized nerves just before travelling beneath the posterior longitudinal ligament. It was not possible to follow them further. The “other sinuvertebral nerve” coursed cephalomedially until dividing into two approximately equally sized branches, just medial to the posterior longitudinal ligament. One branch coursed directly medially onto the basivertebral foramen, the other coursed cephalad.
L4 left: This sinuvertebral nerve coursed cephalomedially until it neared the edge of the posterior longitudinal ligament, where it divided into two branches. The inferior branch coursed caudad, parallel to the border of the posterior longitudinal ligament. The other coursed cephalad, immediately lateral to the border of the posterior longitudinal ligament before branching at the level of the inferior pedicle, creating a branch that coursed medially, beneath the posterior longitudinal ligament, to enter the basivertebral foramen.
L4 Right: This sinuvertebral nerve coursed directly medial, sending small branches cephalad and caudad shortly after entering the epidural space. The larger central branch continued medial until immediately after passing beneath the posterior longitudinal ligament, it divided into 2 nearly equal branches. One of these coursed inferiorly and medially, the other coursed cephalomedially directly to the basivertebral foramen.
L3 Left: The sinuvertebral nerve coursed cephalomedially to about the level of the middle of the L3 pedicle, where it trifurcated, sending one branch caudad, one branch cephalolaterally, and one branch medially. The medial branch coursed directly toward the basivertebral foramen, and divided into three smaller nerves at the basivertebral foramen, all of which entered the basivertebral foramen.
L3 Right: This sinuvertebral nerve had a curved course, travelling cephalomedially, trifurcating at the level of the lateral border of the posterior longitudinal ligament. A very small branch coursed directly caudad. The remaining branches were equivalent in size. One travelled cephalad, the other coursed medially and slightly inferiorly to enter the basivertebral foramen.
Cadaver D
L5 left: The sinuvertebral nerve entered the epidural space coursing medially, and did not branch until approximately 3 mm medial to the medial border of the pedicle where it began coursing cephalad. The first branch coursed medially directly to the basivertebral foramen. A second medial branch was seen that also coursed directly to the basivertebral foramen. The sinuvertebral nerve continued to course cephalad, and was not explored as it travelled past the upper border of the pedicle.
L5 right: Two small nerves exited the root, just beyond the pedicle and coursed back into the spinal canal. The caudad nerve coursed inferiorly. The second coursed medially for approx 0.3 cm before curving cephalad at the level of the basivertebral foramen; this nerve branched once, both branches entered the basivertebral foramen.
L4 Left: sinuvertebral nerve coursed into the epidural space, the first branch coursed inferiorly. The larger branch coursed cephalad. At above the level of the middle of the pedicle it split into 4 branches. Two of them coursed directly to the basivertebral foramen, and the other two coursed cephalad.
L4 right: The sinuvertebral nerve coursed medially for approx 3 mm, and then split into 4 branches, one coursed cephalad, one caudad and two coursed to the basivertebral foramen and entered it.
L3 left: the sinuvertebral nerve coursed medially for about 2 mm, then split into 4 nerves. One coursed superiorly, one coursed to the basivertebral foramen and entered it, one coursed medially (inferior to the basivertebral foramen), and one coursed caudad.
L3 right: The sinuvertebral nerve coursed medially approx 4 mm, a branch then traveled caudad, and another traveled obliquely caudad and medial. This branch divided into two, one coursing to the basivertebral nerve and one continuing cephalad
L2 left: The sinuvertebral nerve coursed medially and slightly cephalad before a branch was produced that traveled caudad. A second branch the was seen to course medially, inferior to the basivertebral foramen, the larger branch traveled very close to the basivertebral foramen and a short branch traveled medially to enter the basivertebral foramen, the continuation of this sinuvertebral nerve continued cephalad and branched again medially, above the level of the basivertebral foramen.
L2 right: the sinuvertebral nerve coursed cephalad and medial. The first branch coursed caudad. The second branch coursed cephalad and medial to enter the basivertebral foramen. The other branch continued cephalad.
Cadaver Dissection IV
Designs for Vision surgical loupes (6.0×) were used for visualization of the finer neurovascular structures during the remainder of the dissection.
Cadaver E
L5 left: a large sinuvertebral nerve branched more laterally than most, dividing into three branches; one coursed caudad, one cranially, and the “middle” one coursed directly to the basivertebral foramen where several small branches entered the foramen. Interestingly the larger branch continued cephalad, actually appearing to travel slightly Right of the midline.
L5 Right: This small sinuvertebral nerve coursed directly cephalomedially to enter the basivertebral foramen. No other branches were identified.
L4 left: The sinuvertebral nerve branched into three distinct nerves at the level of the foramen. One branch coursed caudad, one cephalad and the middle branch coursed directly to the basivertebral foramen.
L4 Right: This sinuvertebral nerve coursed very similarly to the sinuvertebral nerve on the Left. A large sinuvertebral nerve divided into 3 nearly equally sized branches at the level of the foramen. One branch curved cephalad, another curved Caudad, and the middle branch coursed directly to the basivertebral foramen.
L3 left: Only one small nerve was identified leaving the root and reentering the canal. This nerve coursed directly to enter the basivertebral foramen without other visible branches.
L3 Right: the sinuvertebral nerve was seen to enter the epidural space in a very medial direction. It divided into two branches at immediately beneath the lateral border of the dural sac. One barge branch coursed caudad. The other branch coursed cephalad, but broke before reaching the level of the inferior border of the pedicle. The broken end could not be reliably identified.
L2 left: the sinuvertebral nerve divided into two nearly equal branches immediately beneath the lateral border of the dural sac. One coursed caudad and medial, the other coursed directly toward the basivertebral foramen. This nerve trifurcated at the basivertebral foramen, sending one branch into the basivertebral foramen, while another branch continued cephalad. A smaller branch coursed inferomedially.
L2 Right: The sinuvertebral nerve abruptly separated into three branches within 2 mm of the dorsal root ganglion, at the level of the lateral border of the pedicle.
One branch coursed inferomedially, another cephalad, and the “middle’ one coursed directly to the basivertebral foramen, and was seen to enter it.
Cadaver F
L5 Right: The sinuvertebral nerve coursed in an almost pure medial direction, before dividing at one point into two branches. One coursed caudad one coursed nearly vertically directly to the basivertebral foramen, which it entered. The remaining branch coursed cephalad.
L5 Left: The nerve entered the epidural space and coursed obliquely in the direction of the basivertebral foramen, approximately 2 mm from the midline it branched, sending one branch to enter the basivertebral foramen, and another to course cephalad. No branches were seen coursing caudad, but it is possible that such were severed during the dissection.
L4 Left: The sinuvertebral nerve coursed medially for approx 3 mm, the first small branch coursed caudad. The larger branch of the sinuvertebral nerve coursed cephalad, at about the level of the inferior border of the pedicle where it divided into two nearly equally sized branches; one branch was seen to travel obliquely cephalad and medial to enter the basivertebral foramen. The other branch of the sinuvertebral nerve continued cephalad.
L4 Right: The sinuvertebral nerve coursed medial and cephalad. No branch was identified coursing caudad. At approximately the level of the inferior border of the L4 pedicle, a large branch diverged from the sinuvertebral nerve and coursed obliquely medial and cephalad and directly entered the BV foramen. The other branch continued to course cephalad.
L3 Left: The sinuvertebral nerve divided into two large branches while still lateral to the foramen. These branches coursed cephalad and caudad, without sending identifiable branches to the basivertebral foramen
L3 Right: The sinuvertebral nerve was not clearly identifiable at this level, very possibly due to disruption of the anatomy during pedicle removal. Therefore the nerve could not be traced antegrade. When dissection medially was undertaken to attempt a retrograde dissection, a “large” branch of a nerve was found to enter the basivertebral foramen from a cranial direction. Dissection at the L2 level above revealed a large “sinuvertebral nerve” nerve from immediately distal to the L2 ganglion, that coursed directly to the L3 basivertebral foramen; this nerve branched twice at the level of the L2-3 disc, sending small branches medially and laterally. The L2 nerve root also produced a “second sinuvertebral nerve” the coursed medially and centrally at the L2 level. This nerve was not explored further.
Summary
Lumbar Spinal dissection was performed on a total of five cadavers with the successful approach as described. A total of 18 levels, ranging from L1 to S1 were bilaterally exposed. A total of 34 basivertebral nerves were successfully traced from their point of origin at the sinuvertebral nerve, beneath the posterior longitudinal ligament and to the point of entry into the basivertebral foramen. In every case, the innervation of the basivertebral foramen was traced to one or both (L, R) basivertebral nerve branches from the sinuvertebral nerve. In the majority of levels dissected (16118) basivertebral foramen innervations was clearly bilateral. The fragility of the branches of the sinuvertebral nerve has been noted by other authors. It is suspected that nerve breakage during dissection may have allowed some branches of the sinuvertebral nerve to have remained undetected. The typical anatomy is illustrated in
Discussion
The paraspinal neuroanatomy (including innervation of the disc) has been extensively described. The innervation of the vertebral body has been documented as well. The neuroanatomical communication between paraspinal and intervertebral innervation and its implications has been less studied. In this study, emphasis was placed on the proximal basivertebral system, following the basivertebral nerve to its point of origin. As described above, the basivertebral nerve system originates as a medial branch of the sinuvertebral nerve.
The sinuvertebral nerve was specifically identified as a branch of the exiting lumbar nerve root. The sinuvertebral nerve was clearly seen to course back into the ventral epidural space, and usually was seen to branch into at least three easily identifiable branches.
In this study, the medial branches of the nerve were followed as they course underneath the posterior longitudinal ligament. The largest medial branches of the sinuvertebral nerve were seen to course under the posterior longitudinal ligament, and directly enter the basivertebral foramen. Such branches were seen at every level dissected. The basivertebral nerve was consistently present bilaterally.
Imaging and External Radiation of Basivertebral Nerve
Although the location of the basivertebral nerve is somewhat well known, the basivertebral nerve is a normally functioning anatomical feature that is radiolucent, so its precise location cannot be easily identified by an X-ray, angiography, or other indirect imaging methods. Since the basivertebral nerve may also be extremely thin in some embodiments, knowingly directing externally applied energy in close proximity to the basivertebral nerve, without risk to neighboring anatomy, may be problematic.
Several embodiments of the invention access the basivertebral nerve outside of the vertebral body, and denervate the basivertebral nerve to cut off or reduce conduction within the nerve (permanently or temporarily) to downstream locations within the vertebral body. Several embodiments of the invention predictably identify and treat the basivertebral nerve via an energy source located external to the skin (e.g., extracorporeal treatment) or external to the vertebral body of the patient (e.g., human or animal subject).
Several embodiments of the invention are directed to devices and methods for treating back pain by modulating (e.g., denervating, stimulating) the basivertebral nerve from an energy source located external to the body (e.g., external to the skin). While the embodiments listed below are directed to systems and methods that utilize radiation as the primary therapeutic energy modality, any type of energy capable of being directed to a focused point within the body of a patient (in one embodiment, preferably without destruction of intervening tissues and/anatomy) may be used (e.g., high-intensity or low-intensity focused ultrasound). The energy output may be dynamically controlled by changing the power intensity, the frequency, the angle of dispersion, the focus, or other dynamically controllable parameters. In some embodiments, radioactive implants may deliver energy instead of or in combination with external beam therapy.
For external therapy systems involving ultrasonic energy sources, the neuromodulating effects may include application of focused ultrasound energy to achieve sustained heating, sonication, and/or cavitation. In some embodiments, the focal intensity of the ultrasonic energy may range from about 100 W/cm2 to about 1 MW/cm2, from about 1 kW/cm2 to about 10 kW/cm2, from about 10 kW/cm2 to about 100 kW/cm2 or overlapping ranges thereof. In some embodiments, the frequency of the ultrasonic energy may range from about 500 kHz to about 10 MHz, from about 1 MHz to about 5 MHz, from about 5 MHz to about 10 MHz, or overlapping ranges thereof. In some embodiments, focused ultrasound energy may be selected to heat the tissue within the vertebral body to between about 35° C. and about 90° C., between about 40° C. and about 50° C., between about 45° C. and about 60° C., between about 50° C. and about 70° C., between about 60° C. and about 85° C., or overlapping ranges thereof. The treatment time may range from about 2 seconds to about 1 hour, from about 5 seconds to about 10 seconds, from about 10 seconds to about 30 seconds, from about 20 seconds to about 1 minute, from about 1 minute to about 5 minutes, from about 5 minutes to about 10 minutes, from about 10 minutes to about 20 minutes, from about 20 minutes to about 40 minutes, from about 30 minutes to about 45 minutes, from about 40 minutes to about 60 minutes, or overlapping ranges thereof.
Referring to
In one embodiment, one or more radiation sources 330 are disposed in a moveable gantry 312 that is allowed to translate in (x, y, z) directions via linear drive 322.
In
In accordance with several embodiments, gantry 312 is shown in
In accordance with several embodiments, in order to treat the basivertebral nerve of vertebral body 352, which is deep within the body of the patient, the radiation 335 penetrates the intervening healthy tissue in order to irradiate and modulate (e.g., denervate) the basivertebral nerve. In several embodiments, the treatment is performed without exposing large volumes of healthy tissue to harmful doses of radiation, thereby resulting in reduced recovery periods for the patient. In some embodiments, the patient is treated with ionizing radiation and treatment protocols so as to expose the target tissue to a dose of radiation that results in the desired cell modification, while keeping the exposure of healthy tissue to a minimum.
In order to avoid excessive doses being applied to healthy tissue, in some embodiments, the incident direction may be varied throughout the treatment period (e.g., by rotating gantry 312 with the various beams of radiation 335 each converging on a single point). Radial drive 324 may thus be employed to rotate the gantry 312 about the z-axis as shown in
In some embodiments, a large number of radiation sources 330 (e.g., from about 200 to about 300, from about 50 to about 100, from about 100 to about 200, overlapping ranges thereof, over 200) may be employed at a lower dose that individually have a negligible effect on intervening tissue. The single center point (Cp) may thereby receive a full dose, while the surrounding areas receive only a minimal dose. It is also possible to employ both a combination of multiple sources 330 and a rotating gantry 312.
Radiation sources 330 may comprise one of a number of different types, e.g., particle beam (proton beam therapy) sources, cobalt-60 based (photon or gamma-ray sources such as found in the Gamma Knife® technology), linear accelerator based (linac source such as that used in the CyberKnife® or Novalis® Tx technology). Gamma Knife® sources may produce gamma rays from the decay of Co-60 at an average energy of 1.25 MeV. The radiation sources 330 may include over 200 sources arrayed to deliver a variety of treatment angles. In some embodiments, linear accelerators emit high energy X-rays, usually referred to as “X-ray therapy” or “photon therapy.” The x-rays are produced from the impact of accelerated electrons striking a high z target (usually tungsten). Linear accelerators therefore can generate any number of energy x-rays (e.g., 6 MV photons). For linear accelerators, the gantry generally moves in space to change the delivery angle.
Referring now to
In some embodiments, the target region T of the basivertebral nerve 354 is located within the cancellous portion of the bone (e.g., to the interior of the outer cortical bone region), and at or proximal to the junction or plexus 362 of the basivertebral nerve 354 having a plurality of branches. In some embodiments, treatment in this region (at or proximal to the junction or plexus 362) is advantageous because only a single portion of the basivertebral nerve 354 need be effectively treated to denervate (temporarily or permanently) the entire downstream nerve system. In contrast, treatment of the basivertebral nerve 354 at locations more downstream than the junction 362 may require the denervation of each individual branch.
Treatment in accordance with several embodiments of the invention can be effectuated by focusing energy 335 in the target region T of the vertebral body 356 located between 60% (point C) and 90% (point A) of the distance between the posterior and anterior ends of the vertebral body. Point A will often reside in the basivertebral foramen 355, and therefore energy directed to that region may not be as contained (basivertebral foramen 355 opens to the vertebral canal 360, containing sensitive anatomy such as the spinal chord) as when directed into the vertebral body at points B or C (which are surrounded at all sides by bone). Point C may run the risk of being downstream from the nerve junction.
In various embodiments, treatment can be effectuated by focusing in the region of the vertebral body located at a region that is more than 1 cm from the outer cortical wall of the vertebral body, within a region that is centered at or about 50% of the distance from the posterior outer cortical wall of the vertebral body to the anterior outer cortical wall, and/or within a region that is between 10% and 90% (e.g., between about 10% and about 60%, between about 20% and about 80%, between about 35% and about 65%, between about 25% and about 75%, between about 10% and about 55%, between about 30% and about 70%, or overlapping ranges thereof) of the distance from the posterior outer cortical wall of the vertebral body to the anterior outer cortical wall.
In accordance with several embodiments, because the basivertebral nerve is not visible from radiographic imaging, a radiographically identifiable reference point RPb may be advantageously established to determine a target treatment site T that corresponds with the correct location within the vertebral body. In
First, imaging data (also called image data) of the target anatomy (e.g., vertebra 352) is acquired at pretreatment imaging step 402. Image data (e.g. real-time or preacquired x-rays) may be obtained from one or more imaging sources 320, and/or from an outside imaging source (e.g., x-ray, CT, MRI, OCT, angiography, Doppler, ultrasound, etc.). The image data may be used to determine coordinates and dimensions of the target vertebra 312 used in acquiring or identifying the target location or treatments site T. In some embodiments, imaging is not performed. In some embodiments, imaging may be supplemented or replaced by non-imaging techniques that facilitate targeted treatment. In one embodiment, imaging is performed using the same system (e.g., transducer) that provides therapy.
In one embodiment, patient feedback may be obtained through a series of steps 404 through 418 to verify that source center point Cp is correctly positioned at the target treatment site T. In one embodiment, this verification is achieved by determining a pretreatment dose location (PDL) at step 404, which corresponds to the physician's (and/or other medical practitioner's) best estimate for the target basivertebral nerve location T, and delivering one or more identification doses. In another embodiment, the pretreatment dose location PDL is assumed to be the target location T, and the treatment dose TD is delivered at step 420, effectively skipping feedback steps 404 through 418.
In accordance with several embodiments, determining the pretreatment dose location PDL at step 404 generally involves analysis of data acquired from pretreatment imaging step 402. Reference points RPb and RPr (shown in
In one embodiment, at step 408, an identification dose is delivered to the pretreatment dose location PDL. This identification dose is generally a fraction of the treatment dose TD, and may be prescribed to elicit some response from the patient relating to the patient's pain. At step 410, patient feedback is acquired to verify a change in the sensation of pain within the region. The patient's change in pain sensation may be positive (e.g., temporarily alleviate or lessen pain via numbing effect, etc.) or negative (e.g., the small dose aggravates the nerve ends, thereby causing more pain).
If no change in pain is experienced by the patient 350, the source 330 center point Cp may be adjusted to a new pretreatment dose location (PDLx) at step 414. In some embodiments, an additional identification dose is then delivered at step 416. Patient feedback is then elicited for some change in sensation relating to the patient's pain at step 418. If no change in pain is still experienced by the patient 350, the source 330 center point Cp may be adjusted to yet another pretreatment dose location (PDLx) at step 414. In some embodiments, the loop continues in a scanning fashion until the patient identifies a change in pain sensation, thus verifying that the target dose location T is the last treatment dose location (PDL) at step 412.
Next, in accordance with several embodiments, the treatment dose TD is delivered to the target T. Embodiments with radial drive 324 may be operated to change the delivery angle during treatment and minimize the dose to non-target tissues. The treatment dose TD is generally prescribed before treatment, and can be a factor of the patient's age, anatomy, desired treatment volume 364 (see
In one embodiment, the prescribed treatment dose is configured to deliver therapeutic treatment that is targeted to block nerve conduction without ablating the nerve, e.g., thermal treatment is delivered to the nerve that results in denervation of the basivertebral nerve 354 without necrosis of tissue. This denervation without ablation or necrosis may be achieved via delivery of a lesser amount of energy or agent to the tissue site (either in the form of less exposure time, concentration, intensity, etc.) than is required for ablation, but an amount sufficient to achieve some amount of temporary or permanent denervation.
In one embodiment, the treatment dose for delivery of gamma radiation delivered to the patient will typically range between 10 Gy and 70 Gy (e.g., between about 10 Gy and about 30 Gy, between about 20 Gy and about 50 Gy, between about 30 Gy and about 60 Gy, between about 40 Gy and about 70 Gy, or overlapping ranges thereof). However, because the treatment region is contained within the large bony mass vertebral body 356, higher doses may be contemplated, as there is little risk to surrounding tissues that are more vulnerable. The dose may be varied based on the treatment volume 364, or other variables, such as treatment time and dose concentration. A prescription of 35 instances of a 2 Gy dose might be replaced by 15 instances of a 3 Gy dose, a technique known as “hypofractionation.” Taken to its logical extreme, this dose might be replaced with a single 45 Gy dose if the dosage delivered to healthy tissue can be reduced significantly.
In several embodiments, the identification dose used in steps 408 through 416 is generally a much smaller dose than treatment dose TD, so as not to damage healthy tissue. An example dose may range from 0.5 Gy to 5 Gy (e.g., between about 0.5 Gy and about 2 Gy, between about 1 Gy and about 2.5 Gy, between about 1.5 Gy and about 3 Gy, between about 2 Gy and about 5 Gy, or overlapping ranges thereof. However, this range may also change based on considerations such as anatomy, patient, etc.
In some embodiments, one or more radioactive implants are used to deliver radiotherapy instead of or in combination with external beam therapy. The one or more radioactive implants may be inductively powered or activated from outside the body over time (e.g., periodically or as desired or required). In some embodiments, the radioactive implants include an internal battery. The radioactive implants may deliver radioactive therapy over time without additional activation. The radioactive implants may be permanent or removable. In some embodiments, a radioactive implant comprises a plurality of radioactive sources or a plurality of radioactive seeds. In accordance with several embodiments, treatment time is subject to rate of radioactive decay of the radioactive implants. In some embodiments, the radiotherapy is delivered over a matter of minutes (e.g., 10 to 60 minutes, 20 to 40 minutes, 15 to 50 minutes, or overlapping ranges thereof), a matter of hours (e.g., 1 to 24 hours, 2 to 6 hours, 8-12 hours, or overlapping ranges thereof), a matter of days (e.g., 1 to 3 days, 2 to 8 days, 2 to 4 days, or overlapping ranges thereof), a matter of months (e.g., 1 to 12 months, 2 to 6 months, 4 to 10 months, 3 to 9 months, or overlapping ranges thereof), or a matter of years (e.g., 1 to 10 years, 2 to 6 years, 3 to 6 years, or overlapping ranges thereof).
Referring now to
While motion tracking dosing routine 420 of
Although the treatments and therapies were described with reference to intraosseous nerves (e.g., basivertebral nerves) within the spine, the disclosed methods and systems may be used to modulate (e.g., ablate, stimulate) nerves within other bones in other locations of the body.
Conditional language, for example, among others, “can,” “could,” “might,” or “may,” unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements and/or steps.
Although certain embodiments and examples have been described herein, aspects of the methods and devices shown and described in the present disclosure may be differently combined and/or modified to form still further embodiments. Additionally, the methods described herein may be practiced using any device suitable for performing the recited steps. Some embodiments have been described in connection with the accompanying drawings. However, it should be understood that the figures are not drawn to scale. Distances, angles, etc. are merely illustrative and do not necessarily bear an exact relationship to actual dimensions and layout of the devices illustrated. Components can be added, removed, and/or rearranged. Further, the disclosure (including the figures) herein of any particular feature, aspect, method, property, characteristic, quality, attribute, element, or the like in connection with various embodiments can be used in all other embodiments set forth herein.
For purposes of this disclosure, certain aspects, advantages, and novel features of the inventions are described herein. Embodiments embodied or carried out in a manner may achieve one advantage or group of advantages as taught herein without necessarily achieving other advantages. The headings used herein are merely provided to enhance readability and are not intended to limit the scope of the embodiments disclosed in a particular section to the features or elements disclosed in that section. The features or elements from one embodiment of the disclosure can be employed by other embodiments of the disclosure. For example, features described in one figure may be used in conjunction with embodiments illustrated in other figures.
Embodiments of the invention may be described with reference to flowchart illustrations of methods and systems according to embodiments of the invention, and/or algorithms, formulae, or other computational depictions, which may also be implemented as computer program products. In this regard, each block or step of a flowchart, and combinations of blocks (and/or steps) in a flowchart, algorithm, formula, or computational depiction can be implemented by various means, such as hardware, firmware, and/or software including one or more computer program instructions embodied in computer-readable program code logic. As will be appreciated, any such computer program instructions may be loaded onto a computer, including without limitation a general purpose computer or special purpose computer, or other programmable processing apparatus to produce a machine, such that the computer program instructions which execute on the computer or other programmable processing apparatus create means for implementing the functions specified in the block(s) of the flowchart(s).
Accordingly, blocks of the flowcharts, algorithms, formulae, or computational depictions support combinations of means for performing the specified functions, combinations of steps for performing the specified functions, and computer program instructions, such as embodied in computer-readable program code logic means, for performing the specified functions. It will also be understood that each block of the flowchart illustrations, algorithms, formulae, or computational depictions and combinations thereof described herein, can be implemented by special purpose hardware-based computer systems which perform the specified functions or steps, or combinations of special purpose hardware and computer-readable program code logic means.
Furthermore, these computer program instructions, such as embodied in computer-readable program code logic, may also be stored in a computer-readable memory that can direct a computer or other programmable processing apparatus to function in a particular manner, such that the instructions stored in the computer-readable memory produce an article of manufacture including instruction means which implement the function specified in the block(s) of the flowchart(s). The computer program instructions may also be loaded onto a computer or other programmable processing apparatus to cause a series of operational steps to be performed on the computer or other programmable processing apparatus to produce a computer-implemented process such that the instructions which execute on the computer or other programmable processing apparatus provide steps for implementing the functions specified in the block(s) of the flowchart(s), algorithm(s), formula(e), or computational depiction(s).
Although the description above contains many details, these should not be construed as limiting the scope of the invention but as merely providing illustrations of some of the embodiments of this invention. Therefore, it will be appreciated that the scope of the invention fully encompasses other embodiments which may become obvious to those skilled in the art, and that the scope of the invention is accordingly to be limited by nothing other than the appended claims, in which reference to an element in the singular is not intended to mean “one and only one” unless explicitly so stated, but rather “one or more.”
This application is a continuation of U.S. patent application Ser. No. 14/369,661, filed Jun. 27, 2014, now U.S. Pat. No. 10,390,877, which is a 371 U.S. national phase entry of International Application No. PCT/US2012/071465, filed Dec. 21, 2012, which claims the benefit of U.S. Provisional Application No. 61/582,170 filed Dec. 30, 2011 and U.S. Provisional Application No. 61/582,165 filed Dec. 30, 2011, the entire contents of each of which are hereby expressly incorporated herein by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3054881 | Metz et al. | Sep 1962 | A |
| 3062876 | Pons, Jr. et al. | Nov 1962 | A |
| 3565062 | Kuris | Feb 1971 | A |
| 3822708 | Zilber | Jul 1974 | A |
| 3845771 | Vise | Nov 1974 | A |
| 3920021 | Hiltebrandt | Nov 1975 | A |
| 3938502 | Born | Feb 1976 | A |
| 3997408 | MacKew | Aug 1976 | A |
| 4044774 | Corgin et al. | Aug 1977 | A |
| 4116198 | Roos | Sep 1978 | A |
| 4311154 | Sterzer et al. | Jan 1982 | A |
| 4312364 | Convert et al. | Jan 1982 | A |
| 4378806 | Henley-Cohn | Apr 1983 | A |
| 4448198 | Turner | May 1984 | A |
| 4449528 | Auth et al. | May 1984 | A |
| 4462408 | Silverstein et al. | Jul 1984 | A |
| 4528979 | Marchenko et al. | Jul 1985 | A |
| 4530360 | Rate | Jul 1985 | A |
| 4541423 | Barber | Sep 1985 | A |
| 4569351 | Tang | Feb 1986 | A |
| 4573448 | Kambin | Mar 1986 | A |
| 4586512 | Do-huu | May 1986 | A |
| 4601296 | Yerushalmi | Jul 1986 | A |
| 4612940 | Kasevich et al. | Sep 1986 | A |
| 4657017 | Sorochenko | Apr 1987 | A |
| 4662383 | Sogawa et al. | May 1987 | A |
| 4671293 | Shalov | Jun 1987 | A |
| 4676258 | Inokuchi et al. | Jun 1987 | A |
| 4679561 | Doss | Jul 1987 | A |
| 4681122 | Winters et al. | Jul 1987 | A |
| 4750499 | Hoffer | Jun 1988 | A |
| 4754757 | Feucht | Jul 1988 | A |
| 4757820 | Itoh | Jul 1988 | A |
| 4774967 | Zanakis et al. | Oct 1988 | A |
| 4800899 | Elliott | Jan 1989 | A |
| 4813429 | Eshel et al. | Mar 1989 | A |
| 4841977 | Griffith et al. | Jun 1989 | A |
| 4907589 | Cosman | Mar 1990 | A |
| 4924863 | Sterzer | May 1990 | A |
| 4936281 | Stasz | Jun 1990 | A |
| 4941466 | Romano | Jul 1990 | A |
| 4950267 | Ishihara et al. | Aug 1990 | A |
| 4951677 | Crowley et al. | Aug 1990 | A |
| 4955377 | Lennox et al. | Sep 1990 | A |
| 4959063 | Kojima | Sep 1990 | A |
| 4961435 | Kitagawa et al. | Oct 1990 | A |
| 4963142 | Loertscher | Oct 1990 | A |
| 4966144 | Rochkind et al. | Oct 1990 | A |
| 4967765 | Turner et al. | Nov 1990 | A |
| 4976711 | Parins et al. | Dec 1990 | A |
| 4977902 | Sekino et al. | Dec 1990 | A |
| 5000185 | Yock | Mar 1991 | A |
| 5002058 | Marinelli | Mar 1991 | A |
| 5002059 | Crowley et al. | Mar 1991 | A |
| 5007437 | Sterzer | Apr 1991 | A |
| 5025778 | Silverstein et al. | Jun 1991 | A |
| 5031618 | Mullett | Jul 1991 | A |
| 5061266 | Hakky | Oct 1991 | A |
| 5070879 | Herres | Dec 1991 | A |
| RE33791 | Carr | Jan 1992 | E |
| 5078736 | Behl | Jan 1992 | A |
| 5080660 | Buelna | Jan 1992 | A |
| 5084043 | Hertzmann et al. | Jan 1992 | A |
| 5090414 | Takano | Feb 1992 | A |
| 5098431 | Rydell | Mar 1992 | A |
| 5106376 | Mononen et al. | Apr 1992 | A |
| 5108404 | Scholten et al. | Apr 1992 | A |
| 5131397 | Crowley et al. | Jul 1992 | A |
| 5147355 | Friedman et al. | Sep 1992 | A |
| 5156157 | Valenta, Jr. et al. | Oct 1992 | A |
| 5158536 | Sekins et al. | Oct 1992 | A |
| 5161533 | Prass et al. | Nov 1992 | A |
| 5167231 | Matsui | Dec 1992 | A |
| 5186177 | O'Donnell et al. | Feb 1993 | A |
| 5190540 | Lee | Mar 1993 | A |
| 5190546 | Jervis | Mar 1993 | A |
| 5201729 | Hertzmann et al. | Apr 1993 | A |
| 5207672 | Martinelli et al. | May 1993 | A |
| 5209748 | Daikuzono | May 1993 | A |
| 5222953 | Dowlatshahi | Jun 1993 | A |
| 5226430 | Spear et al. | Jul 1993 | A |
| 5242439 | Larsen et al. | Sep 1993 | A |
| 5255679 | Imran | Oct 1993 | A |
| 5271408 | Breyer et al. | Dec 1993 | A |
| 5273026 | Wilk | Dec 1993 | A |
| 5281213 | Milder et al. | Jan 1994 | A |
| 5281215 | Milder et al. | Jan 1994 | A |
| 5282468 | Klepinski | Feb 1994 | A |
| 5292321 | Lee | Mar 1994 | A |
| 5295484 | Marcus et al. | Mar 1994 | A |
| 5300085 | Yock | Apr 1994 | A |
| 5304214 | DeFord et al. | Apr 1994 | A |
| 5305756 | Entrekin et al. | Apr 1994 | A |
| 5314463 | Camps et al. | May 1994 | A |
| 5320617 | Leach | Jun 1994 | A |
| 5324255 | Pasafaro et al. | Jun 1994 | A |
| 5325860 | Seward et al. | Jul 1994 | A |
| 5342292 | Nita et al. | Aug 1994 | A |
| 5342357 | Nardella | Aug 1994 | A |
| 5342409 | Mullett | Aug 1994 | A |
| 5344435 | Turner et al. | Sep 1994 | A |
| 5345940 | Seward et al. | Sep 1994 | A |
| 5348554 | Imran et al. | Sep 1994 | A |
| 5350377 | Winston et al. | Sep 1994 | A |
| 5351691 | Brommersma | Oct 1994 | A |
| 5366443 | Eggers et al. | Nov 1994 | A |
| 5366490 | Edwards et al. | Nov 1994 | A |
| 5368031 | Cline et al. | Nov 1994 | A |
| 5368035 | Hamm et al. | Nov 1994 | A |
| 5368557 | Nita et al. | Nov 1994 | A |
| 5368558 | Nita | Nov 1994 | A |
| 5370675 | Edwards et al. | Dec 1994 | A |
| 5370678 | Edwards et al. | Dec 1994 | A |
| 5372138 | Crowley et al. | Dec 1994 | A |
| 5374265 | Sand | Dec 1994 | A |
| 5383876 | Nardella | Jan 1995 | A |
| 5385148 | Lesh et al. | Jan 1995 | A |
| 5385544 | Edwards et al. | Jan 1995 | A |
| 5391197 | Burdette et al. | Feb 1995 | A |
| 5391199 | Ben-Halm | Feb 1995 | A |
| 5405376 | Mulier et al. | Apr 1995 | A |
| 5411527 | Alt | May 1995 | A |
| 5417719 | Hull et al. | May 1995 | A |
| 5419767 | Eggers et al. | May 1995 | A |
| 5421338 | Crowley | Jun 1995 | A |
| 5423811 | Imran et al. | Jun 1995 | A |
| 5431649 | Mulier et al. | Jul 1995 | A |
| 5433739 | Sluijter et al. | Jul 1995 | A |
| D361555 | Bettin et al. | Aug 1995 | S |
| 5437661 | Rieser | Aug 1995 | A |
| 5441499 | Fritzsch | Aug 1995 | A |
| 5441527 | Erickson et al. | Aug 1995 | A |
| 5443463 | Stern et al. | Aug 1995 | A |
| 5447509 | Millis et al. | Sep 1995 | A |
| 5449380 | Chin | Sep 1995 | A |
| 5454373 | Koger et al. | Oct 1995 | A |
| 5458596 | Lax et al. | Oct 1995 | A |
| 5458597 | Edwards et al. | Oct 1995 | A |
| 5471988 | Fujio et al. | Dec 1995 | A |
| 5472441 | Edwards et al. | Dec 1995 | A |
| 5474530 | Passafaro et al. | Dec 1995 | A |
| 5484432 | Sand | Jan 1996 | A |
| 5486170 | Winston et al. | Jan 1996 | A |
| 5501703 | Holsheimer et al. | Mar 1996 | A |
| 5505730 | Edwarrds | Apr 1996 | A |
| 5514130 | Baker | May 1996 | A |
| 5524624 | Tepper et al. | Jun 1996 | A |
| 5526815 | Granz et al. | Jun 1996 | A |
| 5529580 | Hagino et al. | Jun 1996 | A |
| 5540679 | Fram et al. | Jul 1996 | A |
| 5540681 | Strul et al. | Jul 1996 | A |
| 5540684 | Hassler, Jr. | Jul 1996 | A |
| 5545161 | Imran | Aug 1996 | A |
| 5560362 | Silwa, Jr. et al. | Oct 1996 | A |
| 5565005 | Erickson et al. | Oct 1996 | A |
| 5569242 | Lax et al. | Oct 1996 | A |
| 5571088 | Lennox et al. | Nov 1996 | A |
| 5571147 | Sluijter et al. | Nov 1996 | A |
| 5575772 | Lennox | Nov 1996 | A |
| 5575788 | Baker et al. | Nov 1996 | A |
| 5588432 | Crowley | Dec 1996 | A |
| 5596988 | Markle et al. | Jan 1997 | A |
| 5601526 | Chapelon et al. | Feb 1997 | A |
| 5606974 | Castellano et al. | Mar 1997 | A |
| 5609151 | Mulier et al. | Mar 1997 | A |
| 5620479 | Diederich | Apr 1997 | A |
| 5628317 | Starkebaum et al. | May 1997 | A |
| 5630426 | Shmulewitz et al. | May 1997 | A |
| 5630837 | Crowley | May 1997 | A |
| 5643319 | Green et al. | Jul 1997 | A |
| 5643330 | Holshlemer et al. | Jul 1997 | A |
| 5647361 | Damadian | Jul 1997 | A |
| 5647871 | Levine et al. | Jul 1997 | A |
| 5658278 | Imran et al. | Aug 1997 | A |
| 5672173 | Gough et al. | Sep 1997 | A |
| 5681282 | Eggers et al. | Oct 1997 | A |
| 5683366 | Eggers et al. | Nov 1997 | A |
| 5685839 | Baker et al. | Nov 1997 | A |
| 5687729 | Schaetzle | Nov 1997 | A |
| 5688267 | Panescu | Nov 1997 | A |
| 5693052 | Weaver | Dec 1997 | A |
| 5697281 | Eggers et al. | Dec 1997 | A |
| 5697536 | Eggers et al. | Dec 1997 | A |
| 5697882 | Eggers et al. | Dec 1997 | A |
| 5697909 | Eggers et al. | Dec 1997 | A |
| 5697927 | Imran et al. | Dec 1997 | A |
| 5700262 | Acosta et al. | Dec 1997 | A |
| 5718231 | Chen et al. | Feb 1998 | A |
| 5720286 | Chapelon et al. | Feb 1998 | A |
| 5720287 | Chapelon et al. | Feb 1998 | A |
| 5722403 | McGee et al. | Mar 1998 | A |
| 5725494 | Brisken | Mar 1998 | A |
| 5728062 | Brisken | Mar 1998 | A |
| 5730706 | Garnies | Mar 1998 | A |
| 5733315 | Burdette et al. | Mar 1998 | A |
| 5735280 | Sherman et al. | Apr 1998 | A |
| 5735811 | Brisken | Apr 1998 | A |
| 5735846 | Fleischman et al. | Apr 1998 | A |
| 5735847 | Gough et al. | Apr 1998 | A |
| 5738680 | Mueller et al. | Apr 1998 | A |
| 5741249 | Moss et al. | Apr 1998 | A |
| 5743904 | Edwards | Apr 1998 | A |
| 5746737 | Saadat | May 1998 | A |
| 5752969 | Cunei et al. | May 1998 | A |
| 5755663 | Johnson et al. | May 1998 | A |
| 5762066 | Law et al. | Jun 1998 | A |
| 5762616 | Talish | Jun 1998 | A |
| 5766153 | Eggers et al. | Jun 1998 | A |
| 5766231 | Erickson et al. | Jun 1998 | A |
| 5776092 | Farin et al. | Jul 1998 | A |
| 5785705 | Baker | Jul 1998 | A |
| 5800378 | Edwards et al. | Sep 1998 | A |
| 5800429 | Edwards | Sep 1998 | A |
| 5800432 | Swanson | Sep 1998 | A |
| 5807237 | Tindel | Sep 1998 | A |
| 5807391 | Wljkamp | Sep 1998 | A |
| 5807392 | Eggers | Sep 1998 | A |
| 5807395 | Mulier et al. | Sep 1998 | A |
| 5810764 | Eggers et al. | Sep 1998 | A |
| 5817021 | Reichenberger | Oct 1998 | A |
| 5824021 | Rise | Oct 1998 | A |
| 5840031 | Crowley | Nov 1998 | A |
| 5843019 | Eggers et al. | Dec 1998 | A |
| 5843021 | Edwards et al. | Dec 1998 | A |
| 5844092 | Presta et al. | Dec 1998 | A |
| 5846218 | Brisken et al. | Dec 1998 | A |
| 5849011 | Jones et al. | Dec 1998 | A |
| 5855576 | LeVeen et al. | Jan 1999 | A |
| 5860951 | Eggers et al. | Jan 1999 | A |
| 5865788 | Edwards et al. | Feb 1999 | A |
| 5865801 | Houser | Feb 1999 | A |
| 5868740 | LeVeen et al. | Feb 1999 | A |
| 5871469 | Eggers et al. | Feb 1999 | A |
| 5871470 | McWha | Feb 1999 | A |
| 5871481 | Kannenberg et al. | Feb 1999 | A |
| 5873855 | Eggers et al. | Feb 1999 | A |
| 5873877 | McGaffigan et al. | Feb 1999 | A |
| 5876398 | Mulier et al. | Mar 1999 | A |
| 5888198 | Eggers et al. | Mar 1999 | A |
| 5891095 | Eggers et al. | Apr 1999 | A |
| 5895370 | Edwards et al. | Apr 1999 | A |
| 5902272 | Eggers et al. | May 1999 | A |
| 5902308 | Murphy | May 1999 | A |
| 5904681 | West, Jr. | May 1999 | A |
| 5906613 | Mulier et al. | May 1999 | A |
| 5916213 | Haissaguerre et al. | Jun 1999 | A |
| 5916214 | Cosio | Jun 1999 | A |
| 5919188 | Shearon et al. | Jul 1999 | A |
| 5931805 | Brisken | Aug 1999 | A |
| 5935123 | Edwards et al. | Aug 1999 | A |
| 5938582 | Ciamacco et al. | Aug 1999 | A |
| 5941722 | Chen | Aug 1999 | A |
| 5941876 | Nardella et al. | Aug 1999 | A |
| 5944715 | Goble et al. | Aug 1999 | A |
| 5948007 | Starkebaum et al. | Sep 1999 | A |
| 5948008 | Daikuzono | Sep 1999 | A |
| 5954716 | Sharkey et al. | Sep 1999 | A |
| 5964727 | Edwards et al. | Oct 1999 | A |
| 5967988 | Briscoe et al. | Oct 1999 | A |
| 5972015 | Scribner et al. | Oct 1999 | A |
| 5976105 | Marcove et al. | Nov 1999 | A |
| 5983141 | Sluijter et al. | Nov 1999 | A |
| 5997497 | Nita et al. | Dec 1999 | A |
| 6001095 | de la Rama et al. | Dec 1999 | A |
| 6007533 | Casscells et al. | Dec 1999 | A |
| 6007570 | Sharkey et al. | Dec 1999 | A |
| 6012457 | Lesh | Jan 2000 | A |
| 6014588 | Fitz | Jan 2000 | A |
| 6016452 | Kasevich | Jan 2000 | A |
| 6016809 | Mulier et al. | Jan 2000 | A |
| 6017356 | Frederick et al. | Jan 2000 | A |
| 6019776 | Preissman et al. | Feb 2000 | A |
| 6022334 | Edwards et al. | Feb 2000 | A |
| 6024733 | Eggers et al. | Feb 2000 | A |
| 6024740 | Lesh et al. | Feb 2000 | A |
| 6030374 | McDaniel | Feb 2000 | A |
| 6030402 | Thompson et al. | Feb 2000 | A |
| 6032673 | Langberg et al. | Mar 2000 | A |
| 6032674 | Eggers et al. | Mar 2000 | A |
| 6033411 | Preissman et al. | Mar 2000 | A |
| 6035238 | Ingle et al. | Mar 2000 | A |
| 6038480 | Hrdlicka et al. | Mar 2000 | A |
| 6045532 | Eggers et al. | Apr 2000 | A |
| 6046187 | Berde et al. | Apr 2000 | A |
| 6047214 | Mueller et al. | Apr 2000 | A |
| 6050995 | Durgin | Apr 2000 | A |
| 6053172 | Hovda et al. | Apr 2000 | A |
| 6053909 | Shadduck | Apr 2000 | A |
| 6056745 | Panescu et al. | May 2000 | A |
| 6063078 | Wittkampf | May 2000 | A |
| 6063079 | Hovda et al. | May 2000 | A |
| 6066134 | Eggers et al. | May 2000 | A |
| 6066139 | Ryan et al. | May 2000 | A |
| 6068642 | Johnson et al. | May 2000 | A |
| 6071279 | Whayne et al. | Jun 2000 | A |
| 6073051 | Sharkey et al. | Jun 2000 | A |
| 6074352 | Hynynen et al. | Jun 2000 | A |
| 6086585 | Hovda et al. | Jul 2000 | A |
| 6090105 | Zepeda et al. | Jul 2000 | A |
| 6095149 | Sharkey et al. | Aug 2000 | A |
| 6099499 | Ciamacco | Aug 2000 | A |
| 6099514 | Sharkey et al. | Aug 2000 | A |
| 6099524 | Lipson et al. | Aug 2000 | A |
| 6102046 | Weinstein et al. | Aug 2000 | A |
| 6104957 | Alo et al. | Aug 2000 | A |
| 6105581 | Eggers et al. | Aug 2000 | A |
| 6106454 | Berg et al. | Aug 2000 | A |
| 6109268 | Thapliyal et al. | Aug 2000 | A |
| 6112122 | Schwardt et al. | Aug 2000 | A |
| 6113597 | Eggers et al. | Sep 2000 | A |
| 6117101 | Diederich et al. | Sep 2000 | A |
| 6117109 | Eggers et al. | Sep 2000 | A |
| 6117128 | Gregory | Sep 2000 | A |
| 6120467 | Schallhorn | Sep 2000 | A |
| 6120502 | Michelson | Sep 2000 | A |
| 6122549 | Sharkey et al. | Sep 2000 | A |
| 6126682 | Ashley et al. | Oct 2000 | A |
| 6137209 | Dahlberg et al. | Oct 2000 | A |
| 6139545 | Utley et al. | Oct 2000 | A |
| 6142992 | Cheng et al. | Nov 2000 | A |
| 6143019 | Motamedi et al. | Nov 2000 | A |
| 6146380 | Racz et al. | Nov 2000 | A |
| 6149620 | Baker et al. | Nov 2000 | A |
| 6159194 | Eggers et al. | Dec 2000 | A |
| 6159208 | Hovda et al. | Dec 2000 | A |
| 6161048 | Sluijter et al. | Dec 2000 | A |
| 6164283 | Lesh | Dec 2000 | A |
| 6165172 | Farley et al. | Dec 2000 | A |
| 6168593 | Sharkey et al. | Jan 2001 | B1 |
| 6169924 | Meloy et al. | Jan 2001 | B1 |
| 6171239 | Humphrey | Jan 2001 | B1 |
| 6176857 | Ashley | Jan 2001 | B1 |
| 6179824 | Eggers et al. | Jan 2001 | B1 |
| 6179836 | Eggers et al. | Jan 2001 | B1 |
| 6179858 | Squire et al. | Jan 2001 | B1 |
| 6183469 | Thapliyal et al. | Feb 2001 | B1 |
| 6190381 | Olsen et al. | Feb 2001 | B1 |
| 6190383 | Schmaltz et al. | Feb 2001 | B1 |
| 6193715 | Wrublewski et al. | Feb 2001 | B1 |
| 6203542 | Ellsberry et al. | Mar 2001 | B1 |
| 6206842 | Tu et al. | Mar 2001 | B1 |
| 6210393 | Brisken | Apr 2001 | B1 |
| 6210402 | Olsen et al. | Apr 2001 | B1 |
| 6210415 | Bester | Apr 2001 | B1 |
| 6216704 | Ingle et al. | Apr 2001 | B1 |
| 6221038 | Brisken | Apr 2001 | B1 |
| 6224592 | Eggers et al. | May 2001 | B1 |
| 6228046 | Brisken | May 2001 | B1 |
| 6228078 | Eggers et al. | May 2001 | B1 |
| 6228082 | Baker et al. | May 2001 | B1 |
| 6231516 | Keilman et al. | May 2001 | B1 |
| 6231528 | Kaufman et al. | May 2001 | B1 |
| 6231571 | Ellman et al. | May 2001 | B1 |
| 6231615 | Preissman | May 2001 | B1 |
| 6233488 | Hess | May 2001 | B1 |
| 6235020 | Cheng et al. | May 2001 | B1 |
| 6235022 | Hallock et al. | May 2001 | B1 |
| 6235024 | Tu | May 2001 | B1 |
| 6237604 | Burnside et al. | May 2001 | B1 |
| 6238391 | Olsen et al. | May 2001 | B1 |
| 6238393 | Mulier et al. | May 2001 | B1 |
| 6241665 | Negus et al. | Jun 2001 | B1 |
| 6241725 | Cosman | Jun 2001 | B1 |
| 6241734 | Scribner et al. | Jun 2001 | B1 |
| 6245064 | Lesh | Jun 2001 | B1 |
| 6246912 | Sluijter et al. | Jun 2001 | B1 |
| 6248110 | Reiley et al. | Jun 2001 | B1 |
| 6248345 | Goldenheim et al. | Jun 2001 | B1 |
| 6254553 | Lidgren et al. | Jul 2001 | B1 |
| 6254599 | Lesh et al. | Jul 2001 | B1 |
| 6254600 | Willink et al. | Jul 2001 | B1 |
| 6258086 | Ashley et al. | Jul 2001 | B1 |
| 6259952 | Sluijter | Jul 2001 | B1 |
| 6261311 | Sharkey et al. | Jul 2001 | B1 |
| 6264650 | Hovda et al. | Jul 2001 | B1 |
| 6264651 | Underwood et al. | Jul 2001 | B1 |
| 6264652 | Eggers et al. | Jul 2001 | B1 |
| 6264659 | Ross et al. | Jul 2001 | B1 |
| 6267770 | Truwit | Jul 2001 | B1 |
| 6270498 | Michelson | Aug 2001 | B1 |
| 6277112 | Underwood et al. | Aug 2001 | B1 |
| 6277122 | McGahan et al. | Aug 2001 | B1 |
| 6280441 | Ryan | Aug 2001 | B1 |
| 6280456 | Scribner et al. | Aug 2001 | B1 |
| 6283961 | Underwood et al. | Sep 2001 | B1 |
| 6287114 | Meller et al. | Sep 2001 | B1 |
| 6287272 | Brisken et al. | Sep 2001 | B1 |
| 6287304 | Eggers et al. | Sep 2001 | B1 |
| 6290715 | Sharkey et al. | Sep 2001 | B1 |
| 6292699 | Simon et al. | Sep 2001 | B1 |
| 6296619 | Brisken et al. | Oct 2001 | B1 |
| 6296636 | Cheng et al. | Oct 2001 | B1 |
| 6296638 | Davison et al. | Oct 2001 | B1 |
| 6305378 | Lesh et al. | Oct 2001 | B1 |
| 6309387 | Eggers et al. | Oct 2001 | B1 |
| 6309420 | Preissman | Oct 2001 | B1 |
| 6312408 | Eggers et al. | Nov 2001 | B1 |
| 6312425 | Simpson et al. | Nov 2001 | B1 |
| 6312426 | Goldberg et al. | Nov 2001 | B1 |
| 6319241 | King et al. | Nov 2001 | B1 |
| 6322549 | Eggers et al. | Nov 2001 | B1 |
| 6348055 | Preissman | Feb 2002 | B1 |
| 6355032 | Hovda et al. | Mar 2002 | B1 |
| 6356790 | Maguire et al. | Mar 2002 | B1 |
| 6361531 | Hissong | Mar 2002 | B1 |
| 6363937 | Hovda et al. | Apr 2002 | B1 |
| 6368292 | Ogden et al. | Apr 2002 | B1 |
| 6379351 | Thapliyal et al. | Apr 2002 | B1 |
| 6383190 | Preissman | May 2002 | B1 |
| 6391025 | Weinstein et al. | May 2002 | B1 |
| 6398782 | Pecor et al. | Jun 2002 | B1 |
| 6416507 | Eggers et al. | Jul 2002 | B1 |
| 6416508 | Eggers et al. | Jul 2002 | B1 |
| 6423057 | He et al. | Jul 2002 | B1 |
| 6423059 | Hanson et al. | Jul 2002 | B1 |
| 6425887 | McGuckin et al. | Jul 2002 | B1 |
| 6426339 | Berde et al. | Jul 2002 | B1 |
| 6428491 | Weiss | Aug 2002 | B1 |
| 6432103 | Ellsberry et al. | Aug 2002 | B1 |
| 6436060 | Talish | Aug 2002 | B1 |
| 6436098 | Michelson | Aug 2002 | B1 |
| 6440138 | Reiley et al. | Aug 2002 | B1 |
| 6447448 | Ishikawa et al. | Sep 2002 | B1 |
| 6451013 | Bays et al. | Sep 2002 | B1 |
| 6454727 | Bubank et al. | Sep 2002 | B1 |
| 6461350 | Underwood et al. | Oct 2002 | B1 |
| 6461354 | Olsen et al. | Oct 2002 | B1 |
| 6464695 | Hovda et al. | Oct 2002 | B2 |
| 6468270 | Hovda et al. | Oct 2002 | B1 |
| 6468274 | Alleyne et al. | Oct 2002 | B1 |
| 6470220 | Kraus et al. | Oct 2002 | B1 |
| 6478793 | Cosman et al. | Nov 2002 | B1 |
| 6482201 | Olsen et al. | Nov 2002 | B1 |
| 6485271 | Tack | Nov 2002 | B1 |
| 6487446 | Hill et al. | Nov 2002 | B1 |
| 6491893 | Babich | Dec 2002 | B1 |
| 6493592 | Leonard et al. | Dec 2002 | B1 |
| 6494902 | Hoey et al. | Dec 2002 | B2 |
| 6500173 | Underwood et al. | Dec 2002 | B2 |
| 6505075 | Weiner | Jan 2003 | B1 |
| 6508839 | Lambrecht et al. | Jan 2003 | B1 |
| 6524261 | Talish et al. | Feb 2003 | B2 |
| 6527759 | Tachibana et al. | Mar 2003 | B1 |
| 6537306 | Burdette et al. | Mar 2003 | B1 |
| 6540741 | Underwood et al. | Apr 2003 | B1 |
| 6544261 | Ellsberry et al. | Apr 2003 | B2 |
| 6557559 | Eggers et al. | May 2003 | B1 |
| 6558385 | McClurken et al. | May 2003 | B1 |
| 6558390 | Cragg | May 2003 | B2 |
| 6560486 | Osorio et al. | May 2003 | B1 |
| 6562033 | Shah et al. | May 2003 | B2 |
| 6575919 | Reiley et al. | Jun 2003 | B1 |
| 6575968 | Eggers et al. | Jun 2003 | B1 |
| 6575969 | Rittman, III et al. | Jun 2003 | B1 |
| 6575979 | Cragg | Jun 2003 | B1 |
| 6578579 | Burnside et al. | Jun 2003 | B2 |
| 6582423 | Thapliyal et al. | Jun 2003 | B1 |
| 6585656 | Masters | Jul 2003 | B2 |
| 6589237 | Woloszko et al. | Jul 2003 | B2 |
| 6592559 | Pakter et al. | Jul 2003 | B1 |
| 6595990 | Weinstein et al. | Jul 2003 | B1 |
| 6599288 | Maguire et al. | Jul 2003 | B2 |
| 6602248 | Sharps et al. | Aug 2003 | B1 |
| 6604003 | Fredricks et al. | Aug 2003 | B2 |
| 6607502 | Maguire et al. | Aug 2003 | B1 |
| 6607529 | Jones et al. | Aug 2003 | B1 |
| 6608502 | Aoki et al. | Aug 2003 | B2 |
| 6622731 | Daniel et al. | Sep 2003 | B2 |
| 6623505 | Scribner et al. | Sep 2003 | B2 |
| 6632193 | Davison et al. | Oct 2003 | B1 |
| 6632220 | Eggers et al. | Oct 2003 | B1 |
| 6645202 | Pless et al. | Nov 2003 | B1 |
| 6648883 | Francischelli et al. | Nov 2003 | B2 |
| 6651669 | Burnside | Nov 2003 | B1 |
| 6659106 | Hovda et al. | Dec 2003 | B1 |
| 6663627 | Francischelli et al. | Dec 2003 | B2 |
| 6663647 | Reiley et al. | Dec 2003 | B2 |
| 6673063 | Brett | Jan 2004 | B2 |
| 6689086 | Nita et al. | Feb 2004 | B1 |
| 6689125 | Keith et al. | Feb 2004 | B1 |
| 6692450 | Coleman | Feb 2004 | B1 |
| 6699240 | Francischelli | Mar 2004 | B2 |
| 6699242 | Heggeness | Mar 2004 | B2 |
| 6709432 | Ferek-Patric | Mar 2004 | B2 |
| 6718208 | Hill et al. | Apr 2004 | B2 |
| 6719761 | Reiley et al. | Apr 2004 | B1 |
| 6723087 | O'Neill et al. | Apr 2004 | B2 |
| 6723094 | Desinger | Apr 2004 | B1 |
| 6726684 | Woloszko et al. | Apr 2004 | B1 |
| 6736810 | Hoey et al. | May 2004 | B2 |
| 6736835 | Pellegrino et al. | May 2004 | B2 |
| 6745079 | King | Jun 2004 | B2 |
| 6746447 | Davison et al. | Jun 2004 | B2 |
| 6746451 | Middleton et al. | Jun 2004 | B2 |
| 6749604 | Eggers et al. | Jun 2004 | B1 |
| 6758846 | Goble et al. | Jul 2004 | B2 |
| 6770071 | Woloszko et al. | Aug 2004 | B2 |
| 6772012 | Ricart et al. | Aug 2004 | B2 |
| 6773431 | Eggers et al. | Aug 2004 | B2 |
| 6795737 | Gielen et al. | Sep 2004 | B2 |
| 6805697 | Helm et al. | Oct 2004 | B1 |
| 6827715 | Francischelli et al. | Dec 2004 | B2 |
| 6827716 | Ryan et al. | Dec 2004 | B2 |
| 6832996 | Woloszko et al. | Dec 2004 | B2 |
| 6837887 | Woloszko et al. | Jan 2005 | B2 |
| 6837888 | Ciarrocca et al. | Jan 2005 | B2 |
| 6852091 | Edwards et al. | Feb 2005 | B2 |
| 6863672 | Reiley et al. | Mar 2005 | B2 |
| 6875219 | Arramon et al. | Apr 2005 | B2 |
| 6881214 | Cosman et al. | Apr 2005 | B2 |
| 6896674 | Woloszko et al. | May 2005 | B1 |
| 6896675 | Leung et al. | May 2005 | B2 |
| 6907884 | Pellegrino et al. | Jun 2005 | B2 |
| 6915806 | Pacek et al. | Jul 2005 | B2 |
| 6922579 | Taimisto et al. | Jul 2005 | B2 |
| 6923813 | Phillips et al. | Aug 2005 | B2 |
| 6936046 | Hissong et al. | Aug 2005 | B2 |
| 6955674 | Eick et al. | Oct 2005 | B2 |
| 6960204 | Eggers et al. | Nov 2005 | B2 |
| 6962589 | Mulier et al. | Nov 2005 | B2 |
| 6974453 | Woloszko et al. | Dec 2005 | B2 |
| 6980849 | Sasso | Dec 2005 | B2 |
| 6981981 | Reiiey et al. | Jan 2006 | B2 |
| 6989010 | Francischelli et al. | Jan 2006 | B2 |
| 7001383 | Keidar | Feb 2006 | B2 |
| 7041096 | Malis et al. | May 2006 | B2 |
| 7044954 | Reiley et al. | May 2006 | B2 |
| 7048743 | Miller et al. | May 2006 | B2 |
| 7065408 | Herman et al. | Jun 2006 | B2 |
| 7081122 | Reiley et al. | Jul 2006 | B1 |
| 7090672 | Underwood et al. | Aug 2006 | B2 |
| 7094215 | Davison et al. | Aug 2006 | B2 |
| 7104989 | Skarda | Sep 2006 | B2 |
| 7118574 | Patel et al. | Oct 2006 | B2 |
| 7131969 | Hovda et al. | Nov 2006 | B1 |
| 6997941 | Sharkey et al. | Dec 2006 | B2 |
| 7153307 | Scribner et al. | Dec 2006 | B2 |
| 7163536 | Godara | Jan 2007 | B2 |
| 7177678 | Osorio et al. | Feb 2007 | B1 |
| 7179255 | Lettice et al. | Feb 2007 | B2 |
| 7186234 | Dahla et al. | Mar 2007 | B2 |
| 7192428 | Eggers et al. | Mar 2007 | B2 |
| 7201731 | Lundquist et al. | Apr 2007 | B1 |
| 7201750 | Eggers et al. | Apr 2007 | B1 |
| 7211055 | Diederich et al. | May 2007 | B2 |
| 7217268 | Eggers et al. | May 2007 | B2 |
| 7238184 | Megerman et al. | Jul 2007 | B2 |
| 7241297 | Shaolian et al. | Jul 2007 | B2 |
| 7250048 | Francischelli et al. | Jul 2007 | B2 |
| 7258690 | Sutton et al. | Aug 2007 | B2 |
| 7270659 | Ricart et al. | Sep 2007 | B2 |
| 7270661 | Dahla et al. | Sep 2007 | B2 |
| 7276063 | Davison et al. | Oct 2007 | B2 |
| 7294127 | Leung et al. | Nov 2007 | B2 |
| 7305264 | Larson et al. | Dec 2007 | B2 |
| 7306596 | Hillier et al. | Dec 2007 | B2 |
| 7306598 | Truckai et al. | Dec 2007 | B2 |
| 7318823 | Sharps et al. | Jan 2008 | B2 |
| 7318826 | Teitelbaum et al. | Jan 2008 | B2 |
| 7326203 | Papineau et al. | Feb 2008 | B2 |
| 7331956 | Hovda et al. | Feb 2008 | B2 |
| 7331957 | Woloszko et al. | Feb 2008 | B2 |
| RE40156 | Sharps et al. | Mar 2008 | E |
| 7346391 | Osorio et al. | Mar 2008 | B1 |
| 7386350 | Vilims | Jun 2008 | B2 |
| 7387625 | Hovda et al. | Jun 2008 | B2 |
| 7393351 | Woloszko et al. | Jul 2008 | B2 |
| 7399306 | Reiiey et al. | Jul 2008 | B2 |
| 7422585 | Eggers et al. | Sep 2008 | B1 |
| 7429262 | Woloszko et al. | Sep 2008 | B2 |
| 7435247 | Woloszko et al. | Oct 2008 | B2 |
| 7435250 | Francischelli et al. | Oct 2008 | B2 |
| 7442191 | Hovda et al. | Oct 2008 | B2 |
| 7468059 | Eggers et al. | Dec 2008 | B2 |
| 7480533 | Cosman et al. | Jan 2009 | B2 |
| 7502652 | Gaunt et al. | Mar 2009 | B2 |
| 7503920 | Siegal | Mar 2009 | B2 |
| 7503921 | Siegal | Mar 2009 | B2 |
| 7507236 | Eggers et al. | Mar 2009 | B2 |
| 7546164 | King | Jun 2009 | B2 |
| 7553307 | Bleich et al. | Jun 2009 | B2 |
| 7553309 | Buysse et al. | Jun 2009 | B2 |
| 7555343 | Bleich | Jun 2009 | B2 |
| 7559932 | Truckai et al. | Jul 2009 | B2 |
| 7569626 | Truckai | Aug 2009 | B2 |
| 7574257 | Rittman, III | Aug 2009 | B2 |
| 7585300 | Cha | Sep 2009 | B2 |
| 7593778 | Chandran et al. | Sep 2009 | B2 |
| 7594913 | Ormsby et al. | Sep 2009 | B2 |
| 7604636 | Walters et al. | Oct 2009 | B1 |
| 7621952 | Truckai et al. | Nov 2009 | B2 |
| 7645277 | McClurken et al. | Jan 2010 | B2 |
| 7678111 | Mulier et al. | Mar 2010 | B2 |
| 7678116 | Truckai et al. | Mar 2010 | B2 |
| 7682378 | Truckai et al. | Mar 2010 | B2 |
| 7708733 | Sanders et al. | May 2010 | B2 |
| 7722620 | Truckai et al. | May 2010 | B2 |
| 7731720 | Truckai et al. | Jun 2010 | B2 |
| 7738968 | Bleich | Jun 2010 | B2 |
| 7740631 | Bleich et al. | Jun 2010 | B2 |
| 7749218 | Pellegrino et al. | Jul 2010 | B2 |
| 7749220 | Schmaltz et al. | Jul 2010 | B2 |
| 7780733 | Carver | Aug 2010 | B2 |
| 7792588 | Harding | Sep 2010 | B2 |
| 7799021 | Leung et al. | Sep 2010 | B2 |
| 7819826 | Diederich et al. | Oct 2010 | B2 |
| 7819869 | Godara et al. | Oct 2010 | B2 |
| 7824398 | Woloszko et al. | Nov 2010 | B2 |
| 7824404 | Godara et al. | Nov 2010 | B2 |
| 7828804 | Li et al. | Nov 2010 | B2 |
| 7846156 | Malis et al. | Dec 2010 | B2 |
| 7850685 | Kunis et al. | Dec 2010 | B2 |
| 7853326 | Rittman, III | Dec 2010 | B2 |
| 7857813 | Schmitz et al. | Dec 2010 | B2 |
| 7879032 | Garito et al. | Feb 2011 | B1 |
| 7887543 | Sand et al. | Feb 2011 | B2 |
| 7892235 | Ellis | Feb 2011 | B2 |
| 7896870 | Arless et al. | Mar 2011 | B2 |
| 7896909 | Sharkey et al. | Mar 2011 | B2 |
| 7901403 | Woloszko et al. | Mar 2011 | B2 |
| 7909827 | Reiley et al. | Mar 2011 | B2 |
| 7909873 | Tan-Malecki et al. | Mar 2011 | B2 |
| 7914526 | Lehmann et al. | Mar 2011 | B2 |
| 7914535 | Assell et al. | Mar 2011 | B2 |
| 7917222 | Osorio et al. | Mar 2011 | B1 |
| 7918849 | Bleich et al. | Apr 2011 | B2 |
| 7918874 | Siegel | Apr 2011 | B2 |
| 7938835 | Boucher et al. | May 2011 | B2 |
| 7945331 | Vilims | May 2011 | B2 |
| 7951140 | Arless et al. | May 2011 | B2 |
| 7959634 | Sennett | Jun 2011 | B2 |
| 7963915 | Bleich | Jun 2011 | B2 |
| 7967827 | Osorio et al. | Jun 2011 | B2 |
| 7972340 | Sand et al. | Jul 2011 | B2 |
| 8000785 | Rittman, III | Aug 2011 | B2 |
| 8021401 | Carl et al. | Sep 2011 | B2 |
| 8025688 | Diederich et al. | Sep 2011 | B2 |
| 8034052 | Podhajsky | Oct 2011 | B2 |
| 8034071 | Scribner et al. | Oct 2011 | B2 |
| 8043287 | Conquergood et al. | Oct 2011 | B2 |
| 8048030 | Conquergood et al. | Nov 2011 | B2 |
| 8048071 | Youssef et al. | Nov 2011 | B2 |
| 8048083 | Shadduck et al. | Nov 2011 | B2 |
| 8052661 | McGuckin, Jr. et al. | Nov 2011 | B2 |
| 8062290 | Buysse et al. | Nov 2011 | B2 |
| 8066702 | Rittman, III et al. | Nov 2011 | B2 |
| 8066712 | Truckai et al. | Nov 2011 | B2 |
| 8070753 | Truckai et al. | Dec 2011 | B2 |
| 8082043 | Sharkey et al. | Dec 2011 | B2 |
| 8083736 | McClurken et al. | Dec 2011 | B2 |
| 8096957 | Conquergood et al. | Jan 2012 | B2 |
| 8100896 | Podhajsky | Jan 2012 | B2 |
| 8109933 | Truckai et al. | Feb 2012 | B2 |
| 8123750 | Norton et al. | Feb 2012 | B2 |
| 8123756 | Miller et al. | Feb 2012 | B2 |
| 8128619 | Sharkey et al. | Mar 2012 | B2 |
| 8128633 | Linderman et al. | Mar 2012 | B2 |
| 8162933 | Francischelli et al. | Apr 2012 | B2 |
| 8163031 | Truckai et al. | Apr 2012 | B2 |
| 8172846 | Brunnett et al. | May 2012 | B2 |
| 8182477 | Orszulak et al. | May 2012 | B2 |
| 8187312 | Sharkey et al. | May 2012 | B2 |
| 8192424 | Woloszko et al. | Jun 2012 | B2 |
| 8192435 | Bleich et al. | Jun 2012 | B2 |
| 8216223 | Wham et al. | Jul 2012 | B2 |
| 8226697 | Sharkey et al. | Jul 2012 | B2 |
| 8231616 | McPherson et al. | Jul 2012 | B2 |
| 8241335 | Truckai et al. | Aug 2012 | B2 |
| 8246627 | Vanleeuwen et al. | Aug 2012 | B2 |
| 8265747 | Rittman, III et al. | Sep 2012 | B2 |
| 8282628 | Paul et al. | Oct 2012 | B2 |
| 8292882 | Danek et al. | Oct 2012 | B2 |
| 8292887 | Woloszko et al. | Oct 2012 | B2 |
| 8323277 | Vilims | Dec 2012 | B2 |
| 8323279 | Dahla et al. | Dec 2012 | B2 |
| 8343146 | Godara | Jan 2013 | B2 |
| 8348946 | McClurken et al. | Jan 2013 | B2 |
| 8348955 | Truckai et al. | Jan 2013 | B2 |
| 8355799 | Marion et al. | Jan 2013 | B2 |
| 8361063 | Godara | Jan 2013 | B2 |
| 8361067 | Pellegrino et al. | Jan 2013 | B2 |
| 8406886 | Gaunt et al. | Mar 2013 | B2 |
| 8409289 | Truckai et al. | Apr 2013 | B2 |
| 8414509 | Diederich et al. | Apr 2013 | B2 |
| 8414571 | Pellegrino et al. | Apr 2013 | B2 |
| 8419730 | Pellegrino et al. | Apr 2013 | B2 |
| 8419731 | Pellegrino et al. | Apr 2013 | B2 |
| 8425507 | Pellegrino et al. | Apr 2013 | B2 |
| 8430887 | Truckai et al. | Apr 2013 | B2 |
| 8444636 | Shadduck et al. | May 2013 | B2 |
| 8444640 | Demarais et al. | May 2013 | B2 |
| 8454594 | Demarais et al. | Jun 2013 | B2 |
| 8460382 | Helm et al. | Jun 2013 | B2 |
| 8475449 | Werneth et al. | Jul 2013 | B2 |
| 8486063 | Werneth et al. | Jul 2013 | B2 |
| 8487021 | Truckai et al. | Jul 2013 | B2 |
| 8504147 | Deem et al. | Aug 2013 | B2 |
| 8505545 | Conquergood et al. | Aug 2013 | B2 |
| 8518036 | Leung et al. | Aug 2013 | B2 |
| 8523871 | Truckai et al. | Sep 2013 | B2 |
| 8535309 | Pellegrino et al. | Sep 2013 | B2 |
| 8540723 | Shadduck | Sep 2013 | B2 |
| 8556910 | Truckai et al. | Oct 2013 | B2 |
| 8556911 | Mehta et al. | Oct 2013 | B2 |
| 8560062 | Ritman, III et al. | Oct 2013 | B2 |
| 8562598 | Falkenstein et al. | Oct 2013 | B2 |
| 8562607 | Truckai et al. | Oct 2013 | B2 |
| 8562620 | Truckai et al. | Oct 2013 | B2 |
| 8579903 | Carl | Nov 2013 | B2 |
| 8585694 | Amoah et al. | Nov 2013 | B2 |
| 8591507 | Kramer et al. | Nov 2013 | B2 |
| 8597301 | Mitchell | Dec 2013 | B2 |
| 8603088 | Stern et al. | Dec 2013 | B2 |
| 8613744 | Pellegrino et al. | Dec 2013 | B2 |
| 8617156 | Werneth et al. | Dec 2013 | B2 |
| 8623014 | Pellegrino et al. | Jan 2014 | B2 |
| 8623025 | Tan-Malecki et al. | Jan 2014 | B2 |
| 8628528 | Pellegrino et al. | Jan 2014 | B2 |
| 8636736 | Yates et al. | Jan 2014 | B2 |
| 8644941 | Rooney et al. | Feb 2014 | B2 |
| 8657814 | Werneth et al. | Feb 2014 | B2 |
| 8663266 | Obsuth | Mar 2014 | B1 |
| 8672934 | Benamou et al. | Mar 2014 | B2 |
| 8676309 | Deem et al. | Mar 2014 | B2 |
| 8679023 | Kobayashi et al. | Mar 2014 | B2 |
| 8690884 | Linderman et al. | Apr 2014 | B2 |
| 8696679 | Shadduck et al. | Apr 2014 | B2 |
| RE44883 | Cha | May 2014 | E |
| 8740897 | Leung et al. | Jun 2014 | B2 |
| 8747359 | Pakter et al. | Jun 2014 | B2 |
| 8747398 | Behnke | Jun 2014 | B2 |
| 8758349 | Germain et al. | Jun 2014 | B2 |
| 8764761 | Truckai et al. | Jul 2014 | B2 |
| 8771265 | Truckai | Jul 2014 | B2 |
| 8771276 | Linderman | Jul 2014 | B2 |
| 8774913 | Demarais et al. | Jul 2014 | B2 |
| 8774924 | Weiner | Jul 2014 | B2 |
| 8777479 | Kwan et al. | Jul 2014 | B2 |
| 8784411 | Leuthardt et al. | Jul 2014 | B2 |
| 8795270 | Drake | Aug 2014 | B2 |
| 8808161 | Gregg et al. | Aug 2014 | B2 |
| 8808284 | Pellegrino et al. | Aug 2014 | B2 |
| 8814873 | Schaller et al. | Aug 2014 | B2 |
| 8818503 | Rittman, III | Aug 2014 | B2 |
| 8821488 | Stewart et al. | Sep 2014 | B2 |
| 8845631 | Werneth et al. | Sep 2014 | B2 |
| 8864759 | Godara et al. | Oct 2014 | B2 |
| 8864760 | Kramer et al. | Oct 2014 | B2 |
| 8864777 | Harrison et al. | Oct 2014 | B2 |
| 8882755 | Leung et al. | Nov 2014 | B2 |
| 8882759 | Manley et al. | Nov 2014 | B2 |
| 8882764 | Sutton et al. | Nov 2014 | B2 |
| 8894658 | Linderman et al. | Nov 2014 | B2 |
| 8911497 | Chavatte et al. | Dec 2014 | B2 |
| 8915949 | Diederich et al. | Dec 2014 | B2 |
| 8926620 | Chasmawala et al. | Jan 2015 | B2 |
| 8932300 | Shadduck et al. | Jan 2015 | B2 |
| 8939969 | Temelli et al. | Jan 2015 | B2 |
| 8968288 | Brannan | Mar 2015 | B2 |
| 8989859 | Deem et al. | Mar 2015 | B2 |
| 8992522 | Pellegrino et al. | Mar 2015 | B2 |
| 8992523 | Pellegrino et al. | Mar 2015 | B2 |
| 9005210 | Truckai et al. | Apr 2015 | B2 |
| 9008793 | Cosman, Sr. et al. | Apr 2015 | B1 |
| 9017325 | Pellegrino et al. | Apr 2015 | B2 |
| 9023038 | Pellegrino et al. | May 2015 | B2 |
| 9028488 | Goshayeshgar | May 2015 | B2 |
| 9028538 | Paul et al. | May 2015 | B2 |
| 9039701 | Pellegrino et al. | May 2015 | B2 |
| 9044245 | Condie et al. | Jun 2015 | B2 |
| 9044254 | Ladtkow et al. | Jun 2015 | B2 |
| 9044575 | Beasley et al. | Jun 2015 | B2 |
| 9066769 | Truckai et al. | Jun 2015 | B2 |
| 9078761 | Godara et al. | Jul 2015 | B2 |
| 9095359 | Robert et al. | Aug 2015 | B2 |
| 9113896 | Mulier et al. | Aug 2015 | B2 |
| 9113911 | Sherman | Aug 2015 | B2 |
| 9113925 | Smith et al. | Aug 2015 | B2 |
| 9113950 | Schultz et al. | Aug 2015 | B2 |
| 9113974 | Germain | Aug 2015 | B2 |
| 9119639 | Kuntz | Sep 2015 | B2 |
| 9119647 | Brannan | Sep 2015 | B2 |
| 9119650 | Brannan et al. | Sep 2015 | B2 |
| 9125671 | Germain et al. | Sep 2015 | B2 |
| 9131597 | Taft et al. | Sep 2015 | B2 |
| 9149652 | Wenz et al. | Oct 2015 | B2 |
| 9151680 | Brannan | Oct 2015 | B2 |
| 9155895 | Wacnik et al. | Oct 2015 | B2 |
| 9161735 | Bradford et al. | Oct 2015 | B2 |
| 9161797 | Truckai et al. | Oct 2015 | B2 |
| 9161798 | Truckai et al. | Oct 2015 | B2 |
| 9161805 | Isenberg | Oct 2015 | B2 |
| 9161809 | Germain et al. | Oct 2015 | B2 |
| 9161814 | Brannan et al. | Oct 2015 | B2 |
| 9168054 | Turner et al. | Oct 2015 | B2 |
| 9168078 | Linderman et al. | Oct 2015 | B2 |
| 9168085 | Juzkiw | Oct 2015 | B2 |
| 9173676 | Pellegrino et al. | Nov 2015 | B2 |
| 9173700 | Godara et al. | Nov 2015 | B2 |
| 9179970 | Utley et al. | Nov 2015 | B2 |
| 9179972 | Olson | Nov 2015 | B2 |
| 9180416 | Phan et al. | Nov 2015 | B2 |
| 9186197 | McKay | Nov 2015 | B2 |
| 9192308 | Brannan et al. | Nov 2015 | B2 |
| 9192397 | Sennett et al. | Nov 2015 | B2 |
| 9198684 | Arthur et al. | Dec 2015 | B2 |
| 9216053 | Godara et al. | Dec 2015 | B2 |
| 9226756 | Teisen et al. | Jan 2016 | B2 |
| 9232954 | Steiner et al. | Jan 2016 | B2 |
| 9237916 | Crainich et al. | Jan 2016 | B2 |
| 9238139 | Degiorgio et al. | Jan 2016 | B2 |
| 9241057 | Van Wyk et al. | Jan 2016 | B2 |
| 9241729 | Juntz et al. | Jan 2016 | B2 |
| 9241760 | Godara et al. | Jan 2016 | B2 |
| 9247970 | Teisen | Feb 2016 | B2 |
| 9247992 | Ladtkow et al. | Feb 2016 | B2 |
| 9247993 | Ladtkow et al. | Feb 2016 | B2 |
| 9248278 | Crosby et al. | Feb 2016 | B2 |
| 9248289 | Bennett et al. | Feb 2016 | B2 |
| 9254168 | Palanker | Feb 2016 | B2 |
| 9254386 | Lee et al. | Feb 2016 | B2 |
| 9259241 | Pellegrino et al. | Feb 2016 | B2 |
| 9259248 | Leuthardt et al. | Feb 2016 | B2 |
| 9259269 | Ladtkow et al. | Feb 2016 | B2 |
| 9259569 | Braunstein et al. | Feb 2016 | B2 |
| 9259577 | Kaula et al. | Feb 2016 | B2 |
| 9265522 | Pellegrino et al. | Feb 2016 | B2 |
| 9265557 | Sherman et al. | Feb 2016 | B2 |
| 9277969 | Brannan et al. | Mar 2016 | B2 |
| 9282979 | O'Neil et al. | Mar 2016 | B2 |
| 9282988 | Goshayeshgar | Mar 2016 | B2 |
| 9283015 | Tan-Maiecki et al. | Mar 2016 | B2 |
| 9289607 | Su et al. | Mar 2016 | B2 |
| 9295517 | Peyman et al. | Mar 2016 | B2 |
| 9295841 | Fang et al. | Mar 2016 | B2 |
| 9301723 | Brannan et al. | Apr 2016 | B2 |
| 9301804 | Bonn | Apr 2016 | B2 |
| 9302117 | De Vincentiis | Apr 2016 | B2 |
| 9308036 | Robinson | Apr 2016 | B2 |
| 9308045 | Kim et al. | Apr 2016 | B2 |
| 9314252 | Schaller et al. | Apr 2016 | B2 |
| 9314613 | Mashiach | Apr 2016 | B2 |
| 9314618 | Imran et al. | Apr 2016 | B2 |
| 9333033 | Gliner | May 2016 | B2 |
| 9333144 | Baxter et al. | May 2016 | B2 |
| 9333339 | Weiner | May 2016 | B2 |
| 9333361 | Li et al. | May 2016 | B2 |
| 9333373 | Imran | May 2016 | B2 |
| 9339655 | Carbunaru | May 2016 | B2 |
| 9345530 | Bailakuret | May 2016 | B2 |
| 9345537 | Harrison et al. | May 2016 | B2 |
| 9345538 | Deem et al. | May 2016 | B2 |
| 9351739 | Mahoney et al. | May 2016 | B2 |
| 9358059 | Linderman et al. | Jun 2016 | B2 |
| 9358067 | Lee et al. | Jun 2016 | B2 |
| 9358396 | Holley | Jun 2016 | B2 |
| 9364242 | Tornier et al. | Jun 2016 | B2 |
| 9364286 | Werneth et al. | Jun 2016 | B2 |
| 9370348 | Tally et al. | Jun 2016 | B2 |
| 9370392 | Sharonov | Jun 2016 | B2 |
| 9370398 | Ladtkow et al. | Jun 2016 | B2 |
| 9375274 | Reid | Jun 2016 | B2 |
| 9375275 | Lee et al. | Jun 2016 | B2 |
| 9375278 | Robert et al. | Jun 2016 | B2 |
| 9375279 | Brannan | Jun 2016 | B2 |
| 9375283 | Arts et al. | Jun 2016 | B2 |
| 9381024 | Globerman et al. | Jul 2016 | B2 |
| 9381045 | Donner et al. | Jul 2016 | B2 |
| 9381050 | Lee et al. | Jul 2016 | B2 |
| 9381359 | Parramon et al. | Jul 2016 | B2 |
| 9387094 | Manrique et al. | Jul 2016 | B2 |
| 9393416 | Rooney et al. | Jul 2016 | B2 |
| 9398931 | Wittenberger et al. | Jul 2016 | B2 |
| 9399144 | Howard | Jul 2016 | B2 |
| 9403038 | Tyler | Aug 2016 | B2 |
| 9409023 | Burdick et al. | Aug 2016 | B2 |
| 9414884 | Faehndrich et al. | Aug 2016 | B2 |
| 9421064 | Pellegrino et al. | Aug 2016 | B2 |
| 9421123 | Lee et al. | Aug 2016 | B2 |
| 9421371 | Pless et al. | Aug 2016 | B2 |
| 9421378 | Lian et al. | Aug 2016 | B2 |
| 9439693 | Childs et al. | Sep 2016 | B2 |
| 9439721 | Werneth et al. | Sep 2016 | B2 |
| 9445859 | Pageard | Sep 2016 | B2 |
| 9446229 | Omar-Pasha | Sep 2016 | B2 |
| 9446235 | Su et al. | Sep 2016 | B2 |
| 9452286 | Cowan et al. | Sep 2016 | B2 |
| 9456836 | Boling et al. | Oct 2016 | B2 |
| 9457182 | Koop | Oct 2016 | B2 |
| 9468485 | Wittenberger et al. | Oct 2016 | B2 |
| 9468495 | Kunis et al. | Oct 2016 | B2 |
| 9474565 | Shikhman et al. | Oct 2016 | B2 |
| 9474906 | Sachs et al. | Oct 2016 | B2 |
| 9480485 | Aho et al. | Nov 2016 | B2 |
| 9486279 | Pellegrino et al. | Nov 2016 | B2 |
| 9486447 | Peterson et al. | Nov 2016 | B2 |
| 9486621 | Howard et al. | Nov 2016 | B2 |
| 9492657 | Gerber | Nov 2016 | B2 |
| 9492664 | Peterson | Nov 2016 | B2 |
| 9504372 | Kim | Nov 2016 | B2 |
| 9504481 | Germain et al. | Nov 2016 | B2 |
| 9504506 | Crainich et al. | Nov 2016 | B2 |
| 9504518 | Condie et al. | Nov 2016 | B2 |
| 9504530 | Hartmann et al. | Nov 2016 | B2 |
| 9504818 | Moffitt et al. | Nov 2016 | B2 |
| 9511229 | Bradley | Dec 2016 | B2 |
| 9511231 | Kent et al. | Dec 2016 | B1 |
| 9513761 | Shikhman et al. | Dec 2016 | B2 |
| 9517077 | Blain et al. | Dec 2016 | B2 |
| 9517200 | Bleier | Dec 2016 | B2 |
| 9526507 | Germain | Dec 2016 | B2 |
| 9526551 | Linderman | Dec 2016 | B2 |
| 9526559 | Benamou et al. | Dec 2016 | B2 |
| 9532828 | Condie et al. | Jan 2017 | B2 |
| 9549772 | Carl | Jan 2017 | B2 |
| 9550041 | Bedell | Jan 2017 | B2 |
| 9555037 | Podhajsky | Jan 2017 | B2 |
| 9556101 | Robertson et al. | Jan 2017 | B2 |
| 9556449 | Basu et al. | Jan 2017 | B2 |
| 9566449 | Perryman et al. | Feb 2017 | B2 |
| 9572976 | Howard et al. | Feb 2017 | B2 |
| 9572986 | Moffitt | Feb 2017 | B2 |
| 9579127 | Kostuik et al. | Feb 2017 | B2 |
| 9579518 | Gertner | Feb 2017 | B2 |
| 9597091 | Bromer | Mar 2017 | B2 |
| 9597148 | Olson | Mar 2017 | B2 |
| RE46356 | Pellegrino et al. | Apr 2017 | E |
| 9610083 | Kuntz | Apr 2017 | B2 |
| 9610117 | Germain | Apr 2017 | B2 |
| 9636175 | Stern et al. | May 2017 | B2 |
| 9642629 | Griffiths et al. | May 2017 | B2 |
| 9649116 | Germain | May 2017 | B2 |
| 9681889 | Greenhalgh et al. | Jun 2017 | B1 |
| 9687255 | Sennett et al. | Jun 2017 | B2 |
| 9724107 | Pellegrino et al. | Aug 2017 | B2 |
| 9724151 | Edidin | Aug 2017 | B2 |
| 9730707 | Sasaki et al. | Aug 2017 | B2 |
| 9743854 | Stewart et al. | Aug 2017 | B2 |
| 9743938 | Germain et al. | Aug 2017 | B2 |
| 9750560 | Ballakur et al. | Sep 2017 | B2 |
| 9757193 | Zarins et al. | Sep 2017 | B2 |
| 9770280 | Diederich et al. | Sep 2017 | B2 |
| 9775627 | Patel et al. | Oct 2017 | B2 |
| 9782221 | Srinivasan | Oct 2017 | B2 |
| 9795802 | Mohamed | Oct 2017 | B2 |
| 9814514 | Shelton, IV et al. | Nov 2017 | B2 |
| 9844406 | Edwards et al. | Dec 2017 | B2 |
| 9848944 | Sutton et al. | Dec 2017 | B2 |
| 9872687 | Tornier et al. | Jan 2018 | B2 |
| 9872691 | Griffiths et al. | Jan 2018 | B2 |
| 9877707 | Godara et al. | Jan 2018 | B2 |
| 9913675 | Germain | Mar 2018 | B2 |
| 10028753 | Pellegrino et al. | Jul 2018 | B2 |
| 10028784 | Kramer et al. | Jul 2018 | B2 |
| 10052152 | Tegg et al. | Aug 2018 | B2 |
| 10111674 | Crainich et al. | Oct 2018 | B2 |
| 10111704 | Pellegrino et al. | Oct 2018 | B2 |
| 10123809 | Germain | Nov 2018 | B2 |
| 10245092 | Germain | Apr 2019 | B2 |
| 10265099 | Pellegrino et al. | Apr 2019 | B2 |
| 10272271 | Diederich et al. | Apr 2019 | B2 |
| 10292716 | Aho et al. | May 2019 | B2 |
| 10292719 | Burger et al. | May 2019 | B2 |
| 10299805 | Germain et al. | May 2019 | B2 |
| 10327841 | Germain | Jun 2019 | B2 |
| 10357258 | Patel et al. | Jul 2019 | B2 |
| 10383641 | LeRoy et al. | Aug 2019 | B2 |
| 10390877 | Heggeness et al. | Aug 2019 | B2 |
| 10441295 | Brockman et al. | Oct 2019 | B2 |
| 10448995 | Olson | Oct 2019 | B2 |
| 10456187 | Edidin | Oct 2019 | B2 |
| 10463380 | Purdy et al. | Nov 2019 | B2 |
| 10463423 | Sutton et al. | Nov 2019 | B2 |
| 10470781 | Purdy et al. | Nov 2019 | B2 |
| 10478241 | Purdy et al. | Nov 2019 | B2 |
| 10478246 | Pellegrino et al. | Nov 2019 | B2 |
| 10493247 | Goshayeshgar | Dec 2019 | B2 |
| 10499960 | Sinnott et al. | Dec 2019 | B2 |
| 10517611 | Patel et al. | Dec 2019 | B2 |
| 10524805 | Zilberman et al. | Jan 2020 | B2 |
| 10588691 | Pellegrino et al. | Mar 2020 | B2 |
| 10589131 | Diederich et al. | Mar 2020 | B2 |
| 10603522 | Diederich et al. | Mar 2020 | B2 |
| 10624652 | Germain et al. | Apr 2020 | B2 |
| 10660656 | Purdy et al. | May 2020 | B2 |
| 10898254 | Diederich et al. | Jan 2021 | B2 |
| 10905440 | Pellegrino et al. | Feb 2021 | B2 |
| RE48460 | Pellegrino et al. | Mar 2021 | E |
| 11007010 | Donovan et al. | May 2021 | B2 |
| 11026734 | Truckai et al. | Jun 2021 | B2 |
| 11026744 | Purdy et al. | Jun 2021 | B2 |
| 11052267 | Diederich et al. | Jul 2021 | B2 |
| 11065046 | Edidin | Jul 2021 | B2 |
| 11123103 | Donovan et al. | Sep 2021 | B2 |
| 11160563 | Patel et al. | Nov 2021 | B2 |
| 11207100 | Donovan et al. | Dec 2021 | B2 |
| 11234764 | Patel et al. | Feb 2022 | B1 |
| 20010001314 | Davison et al. | May 2001 | A1 |
| 20010001811 | Burney et al. | May 2001 | A1 |
| 20010020167 | Woloszko et al. | Sep 2001 | A1 |
| 20010023348 | Ashley et al. | Sep 2001 | A1 |
| 20010025176 | Ellsberry et al. | Sep 2001 | A1 |
| 20010025177 | Woloszko et al. | Sep 2001 | A1 |
| 20010027295 | Dulak et al. | Oct 2001 | A1 |
| 20010029370 | Hovda et al. | Oct 2001 | A1 |
| 20010029373 | Baker et al. | Oct 2001 | A1 |
| 20010029393 | Tierney et al. | Oct 2001 | A1 |
| 20010032001 | Ricart et al. | Oct 2001 | A1 |
| 20010047167 | Heggeness | Nov 2001 | A1 |
| 20010049522 | Eggers et al. | Dec 2001 | A1 |
| 20010049527 | Cragg | Dec 2001 | A1 |
| 20010051802 | Woloszko et al. | Dec 2001 | A1 |
| 20010053885 | Gielen et al. | Dec 2001 | A1 |
| 20010056280 | Underwood et al. | Dec 2001 | A1 |
| 20020016583 | Cragg | Feb 2002 | A1 |
| 20020016600 | Cosman | Feb 2002 | A1 |
| 20020019626 | Sharkey et al. | Feb 2002 | A1 |
| 20020026186 | Woloszko et al. | Feb 2002 | A1 |
| 20020049438 | Sharkey et al. | Apr 2002 | A1 |
| 20020095144 | Carl | Apr 2002 | A1 |
| 20020052600 | Davison et al. | May 2002 | A1 |
| 20020068930 | Tasto et al. | Jun 2002 | A1 |
| 20020095151 | Dahla et al. | Jul 2002 | A1 |
| 20020095152 | Ciarrocca et al. | Jul 2002 | A1 |
| 20020099366 | Dahla et al. | Jul 2002 | A1 |
| 20020111661 | Cross et al. | Aug 2002 | A1 |
| 20020115945 | D'Luzansky et al. | Aug 2002 | A1 |
| 20020120259 | Lettice et al. | Aug 2002 | A1 |
| 20020133148 | Daniel et al. | Sep 2002 | A1 |
| 20020147444 | Shah | Oct 2002 | A1 |
| 20020151885 | Underwood et al. | Oct 2002 | A1 |
| 20020165532 | Hill et al. | Nov 2002 | A1 |
| 20020183758 | Middleton et al. | Dec 2002 | A1 |
| 20020188284 | To et al. | Dec 2002 | A1 |
| 20020188290 | Sharkey et al. | Dec 2002 | A1 |
| 20020193708 | Thompson et al. | Dec 2002 | A1 |
| 20020193789 | Underwood et al. | Dec 2002 | A1 |
| 20030009164 | Woloszko et al. | Jan 2003 | A1 |
| 20030014047 | Woloszko et al. | Jan 2003 | A1 |
| 20030014088 | Fang et al. | Jan 2003 | A1 |
| 20030028147 | Aves et al. | Feb 2003 | A1 |
| 20030028189 | Woloszko et al. | Feb 2003 | A1 |
| 20030040742 | Underwood et al. | Feb 2003 | A1 |
| 20030040743 | Cosman et al. | Feb 2003 | A1 |
| 20030055418 | Tasto et al. | Mar 2003 | A1 |
| 20030069569 | Burdette et al. | Apr 2003 | A1 |
| 20030083592 | Faciszewski | May 2003 | A1 |
| 20030084907 | Pacek et al. | May 2003 | A1 |
| 20030097126 | Woloszko et al. | May 2003 | A1 |
| 20030097129 | Davison et al. | May 2003 | A1 |
| 20030130655 | Woloszko et al. | Jul 2003 | A1 |
| 20030139652 | Kang et al. | Jul 2003 | A1 |
| 20030158545 | Hovda et al. | Aug 2003 | A1 |
| 20030181963 | Pellegrino et al. | Sep 2003 | A1 |
| 20030208194 | Hovda et al. | Nov 2003 | A1 |
| 20030216725 | Woloszko et al. | Nov 2003 | A1 |
| 20030216726 | Eggers et al. | Nov 2003 | A1 |
| 20030225364 | Kraft | Dec 2003 | A1 |
| 20040006339 | Underwood et al. | Jan 2004 | A1 |
| 20040015163 | Buysse et al. | Jan 2004 | A1 |
| 20040024399 | Sharps et al. | Feb 2004 | A1 |
| 20040054366 | Davison et al. | Mar 2004 | A1 |
| 20040064023 | Thomas et al. | Apr 2004 | A1 |
| 20040064136 | Crombie et al. | Apr 2004 | A1 |
| 20040064137 | Pellegrino et al. | Apr 2004 | A1 |
| 20040082942 | Katzman | Apr 2004 | A1 |
| 20040082946 | Mails et al. | Apr 2004 | A1 |
| 20040087937 | Eggers et al. | May 2004 | A1 |
| 20040111087 | Stern et al. | Jun 2004 | A1 |
| 20040116922 | Hovda et al. | Jun 2004 | A1 |
| 20040120668 | Loeb | Jun 2004 | A1 |
| 20040120891 | Hill et al. | Jun 2004 | A1 |
| 20040133124 | Bates et al. | Jul 2004 | A1 |
| 20040162559 | Arramon | Aug 2004 | A1 |
| 20040186544 | King | Sep 2004 | A1 |
| 20040193151 | To et al. | Sep 2004 | A1 |
| 20040220577 | Cragg et al. | Nov 2004 | A1 |
| 20040225228 | Ferree | Nov 2004 | A1 |
| 20040230190 | Dahla et al. | Nov 2004 | A1 |
| 20040267269 | Middleton et al. | Dec 2004 | A1 |
| 20050004634 | Ricart et al. | Jan 2005 | A1 |
| 20050010095 | Stewart et al. | Jan 2005 | A1 |
| 20050010203 | Edwards et al. | Jan 2005 | A1 |
| 20050010205 | Hovda et al. | Jan 2005 | A1 |
| 20050043737 | Reiley et al. | Feb 2005 | A1 |
| 20050055096 | Serhan et al. | Mar 2005 | A1 |
| 20050124989 | Suddaby | Jun 2005 | A1 |
| 20050177209 | Leung et al. | Aug 2005 | A1 |
| 20050177210 | Leung et al. | Aug 2005 | A1 |
| 20050177211 | Leung et al. | Aug 2005 | A1 |
| 20050182417 | Pagano | Aug 2005 | A1 |
| 20050192564 | Cosman et al. | Sep 2005 | A1 |
| 20050209610 | Carrison | Sep 2005 | A1 |
| 20050209659 | Pellegrino et al. | Sep 2005 | A1 |
| 20050216018 | Sennett | Sep 2005 | A1 |
| 20050234445 | Conquergood et al. | Oct 2005 | A1 |
| 20050261754 | Woloszko | Nov 2005 | A1 |
| 20050267552 | Conquergood et al. | Dec 2005 | A1 |
| 20050278007 | Godara | Dec 2005 | A1 |
| 20050283148 | Janssen et al. | Dec 2005 | A1 |
| 20060004369 | Patel et al. | Jan 2006 | A1 |
| 20060036264 | Selover | Feb 2006 | A1 |
| 20060052743 | Reynolds | Mar 2006 | A1 |
| 20060064101 | Arramon | Mar 2006 | A1 |
| 20060095026 | Ricart et al. | May 2006 | A1 |
| 20060095028 | Bleich | May 2006 | A1 |
| 20060106375 | Werneth et al. | May 2006 | A1 |
| 20060106376 | Godara et al. | May 2006 | A1 |
| 20060122458 | Bleich | Jun 2006 | A1 |
| 20060129101 | McGuckin | Jun 2006 | A1 |
| 20060178670 | Woloszko et al. | Aug 2006 | A1 |
| 20060200121 | Mowery | Sep 2006 | A1 |
| 20060206128 | Conquergood et al. | Sep 2006 | A1 |
| 20060206129 | Conquergood et al. | Sep 2006 | A1 |
| 20060206130 | Conquergood | Sep 2006 | A1 |
| 20060206132 | Conquergood et al. | Sep 2006 | A1 |
| 20060206133 | Conquergood et al. | Sep 2006 | A1 |
| 20060206134 | Conquergood et al. | Sep 2006 | A1 |
| 20060206166 | Weiner | Sep 2006 | A1 |
| 20060217736 | Kaneko et al. | Sep 2006 | A1 |
| 20060229625 | Truckai et al. | Oct 2006 | A1 |
| 20060247746 | Danek et al. | Nov 2006 | A1 |
| 20060253117 | Hovda et al. | Nov 2006 | A1 |
| 20060259026 | Godara et al. | Nov 2006 | A1 |
| 20060264957 | Cragg et al. | Nov 2006 | A1 |
| 20060264965 | Shadduck et al. | Nov 2006 | A1 |
| 20060265014 | Demarais et al. | Nov 2006 | A1 |
| 20060276749 | Selmon et al. | Dec 2006 | A1 |
| 20060287649 | Ormsby et al. | Dec 2006 | A1 |
| 20070021803 | Deem et al. | Jan 2007 | A1 |
| 20070027449 | Godara et al. | Feb 2007 | A1 |
| 20070055316 | Godara et al. | Mar 2007 | A1 |
| 20070066987 | Scanlan, Jr. et al. | Mar 2007 | A1 |
| 20070074719 | Danek et al. | Apr 2007 | A1 |
| 20070118142 | Krueger et al. | May 2007 | A1 |
| 20070129715 | Eggers et al. | Jun 2007 | A1 |
| 20070142791 | Yeung et al. | Jun 2007 | A1 |
| 20070142842 | Krueger et al. | Jun 2007 | A1 |
| 20070149966 | Dahla et al. | Jun 2007 | A1 |
| 20070179497 | Eggers et al. | Aug 2007 | A1 |
| 20070185231 | Liu et al. | Aug 2007 | A1 |
| 20070213584 | Kim et al. | Sep 2007 | A1 |
| 20070213735 | Saadat et al. | Sep 2007 | A1 |
| 20070260237 | Sutton et al. | Nov 2007 | A1 |
| 20080004621 | Dahla et al. | Jan 2008 | A1 |
| 20080004675 | King | Jan 2008 | A1 |
| 20080009847 | Ricart et al. | Jan 2008 | A1 |
| 20080021447 | Davison et al. | Jan 2008 | A1 |
| 20080021463 | Georgy | Jan 2008 | A1 |
| 20080058707 | Ashley et al. | Mar 2008 | A1 |
| 20080065062 | Leung et al. | Mar 2008 | A1 |
| 20080091207 | Truckai et al. | Apr 2008 | A1 |
| 20080114364 | Goldin et al. | May 2008 | A1 |
| 20080119844 | Woloszko et al. | May 2008 | A1 |
| 20080119846 | Rioux | May 2008 | A1 |
| 20080132890 | Woloszko et al. | Jun 2008 | A1 |
| 20080161804 | Rioux et al. | Jul 2008 | A1 |
| 20080275458 | Bleich et al. | Nov 2008 | A1 |
| 20080281322 | Sherman et al. | Nov 2008 | A1 |
| 20080294166 | Goldin et al. | Nov 2008 | A1 |
| 20080294167 | Schumacher et al. | Nov 2008 | A1 |
| 20090030308 | Bradford et al. | Jan 2009 | A1 |
| 20090054951 | Leuthardt et al. | Feb 2009 | A1 |
| 20090069807 | Eggers et al. | Mar 2009 | A1 |
| 20090076520 | Choi | Mar 2009 | A1 |
| 20090105775 | Mitchell et al. | Apr 2009 | A1 |
| 20090112278 | Wingeier et al. | Apr 2009 | A1 |
| 20090118731 | Young et al. | May 2009 | A1 |
| 20090131867 | Liu et al. | May 2009 | A1 |
| 20090131886 | Liu et al. | May 2009 | A1 |
| 20090149846 | Hoey et al. | Jun 2009 | A1 |
| 20090149878 | Truckai et al. | Jun 2009 | A1 |
| 20090204192 | Carlton et al. | Aug 2009 | A1 |
| 20090222053 | Gaunt et al. | Sep 2009 | A1 |
| 20090312764 | Marino | Dec 2009 | A1 |
| 20100010392 | Skelton et al. | Jan 2010 | A1 |
| 20100016929 | Prochazka | Jan 2010 | A1 |
| 20100023006 | Ellman | Jan 2010 | A1 |
| 20100023065 | Welch et al. | Jan 2010 | A1 |
| 20100082033 | Germain | Apr 2010 | A1 |
| 20100094269 | Pellegrino et al. | Apr 2010 | A1 |
| 20100114098 | Carl | May 2010 | A1 |
| 20100145424 | Podhajsky et al. | Jun 2010 | A1 |
| 20100179556 | Scribner et al. | Jul 2010 | A1 |
| 20100185082 | Chandran et al. | Jul 2010 | A1 |
| 20100185161 | Pellegrino | Jul 2010 | A1 |
| 20100211076 | Germain et al. | Aug 2010 | A1 |
| 20100222777 | Sutton et al. | Sep 2010 | A1 |
| 20100261989 | Boseck et al. | Oct 2010 | A1 |
| 20100261990 | Gillis et al. | Oct 2010 | A1 |
| 20100298737 | Koehler | Nov 2010 | A1 |
| 20100298822 | Behnke | Nov 2010 | A1 |
| 20100298832 | Lau et al. | Nov 2010 | A1 |
| 20100305559 | Brannan et al. | Dec 2010 | A1 |
| 20100324506 | Pellegrino et al. | Dec 2010 | A1 |
| 20110022133 | Diederich et al. | Jan 2011 | A1 |
| 20110034884 | Pellegrino et al. | Feb 2011 | A9 |
| 20110040362 | Godara et al. | Feb 2011 | A1 |
| 20110077628 | Hoey et al. | Mar 2011 | A1 |
| 20110087314 | Diederich et al. | Apr 2011 | A1 |
| 20110118735 | Abou-Marie et al. | May 2011 | A1 |
| 20110130751 | Malis et al. | Jun 2011 | A1 |
| 20110144524 | Fish et al. | Jun 2011 | A1 |
| 20110152855 | Mayse et al. | Jun 2011 | A1 |
| 20110196361 | Vilims | Aug 2011 | A1 |
| 20110206260 | Bergmans et al. | Aug 2011 | A1 |
| 20110264098 | Cobbs | Oct 2011 | A1 |
| 20110270238 | Rizq et al. | Nov 2011 | A1 |
| 20110276001 | Schultz et al. | Nov 2011 | A1 |
| 20110295245 | Willyard et al. | Dec 2011 | A1 |
| 20110295261 | Germain | Dec 2011 | A1 |
| 20110319765 | Gertner | Dec 2011 | A1 |
| 20120029420 | Vilims | Feb 2012 | A1 |
| 20120116266 | Houser et al. | May 2012 | A1 |
| 20120123427 | McGuckin, Jr. | May 2012 | A1 |
| 20120136346 | Condie et al. | May 2012 | A1 |
| 20120136348 | Condie et al. | May 2012 | A1 |
| 20120143090 | Hay et al. | Jun 2012 | A1 |
| 20120143341 | Zipnick | Jun 2012 | A1 |
| 20120172858 | Harrison et al. | Jul 2012 | A1 |
| 20120172859 | Condie et al. | Jul 2012 | A1 |
| 20120191095 | Burger et al. | Jul 2012 | A1 |
| 20120196251 | Taft et al. | Aug 2012 | A1 |
| 20120197344 | Taft et al. | Aug 2012 | A1 |
| 20120203219 | Evans et al. | Aug 2012 | A1 |
| 20120226145 | Chang et al. | Sep 2012 | A1 |
| 20120226273 | Nguyen et al. | Sep 2012 | A1 |
| 20120239049 | Truckai et al. | Sep 2012 | A1 |
| 20120239050 | Linderman | Sep 2012 | A1 |
| 20120265186 | Burger et al. | Oct 2012 | A1 |
| 20120330180 | Pellegrino et al. | Dec 2012 | A1 |
| 20120330300 | Pellegrino et al. | Dec 2012 | A1 |
| 20120330301 | Pellegrino et al. | Dec 2012 | A1 |
| 20130006232 | Pellegrino et al. | Jan 2013 | A1 |
| 20130006233 | Pellegrino et al. | Jan 2013 | A1 |
| 20130012933 | Pellegrino et al. | Jan 2013 | A1 |
| 20130012935 | Pellegrino et al. | Jan 2013 | A1 |
| 20130012936 | Pellegrino et al. | Jan 2013 | A1 |
| 20130012951 | Linderman | Jan 2013 | A1 |
| 20130060244 | Godara et al. | Mar 2013 | A1 |
| 20130079810 | Isenberg | Mar 2013 | A1 |
| 20130197508 | Shikhman et al. | Aug 2013 | A1 |
| 20130231654 | Germain | Sep 2013 | A1 |
| 20130237979 | Shikhman et al. | Sep 2013 | A1 |
| 20130103022 | Sutton et al. | Oct 2013 | A1 |
| 20130261507 | Diederich et al. | Oct 2013 | A1 |
| 20130274784 | Lenker et al. | Oct 2013 | A1 |
| 20130296767 | Zarins et al. | Nov 2013 | A1 |
| 20130324993 | McCarthy et al. | Dec 2013 | A1 |
| 20130324994 | Pellegrino et al. | Dec 2013 | A1 |
| 20130324996 | Pellegrino et al. | Dec 2013 | A1 |
| 20130324997 | Pellegrino et al. | Dec 2013 | A1 |
| 20130331840 | Teisen et al. | Dec 2013 | A1 |
| 20130345765 | Brockman et al. | Dec 2013 | A1 |
| 20140031715 | Sherar et al. | Jan 2014 | A1 |
| 20140039500 | Pellegrino et al. | Feb 2014 | A1 |
| 20140046245 | Cornacchia | Feb 2014 | A1 |
| 20140046328 | Schumacher et al. | Feb 2014 | A1 |
| 20140066913 | Sherman | Mar 2014 | A1 |
| 20140088575 | Loeb | Mar 2014 | A1 |
| 20140148801 | Asher et al. | May 2014 | A1 |
| 20140148805 | Stewart et al. | May 2014 | A1 |
| 20140171942 | Werneth et al. | Jun 2014 | A1 |
| 20140194887 | Shenoy | Jul 2014 | A1 |
| 20140221967 | Childs et al. | Aug 2014 | A1 |
| 20140236137 | Tran et al. | Aug 2014 | A1 |
| 20140236144 | Krueger et al. | Aug 2014 | A1 |
| 20140243823 | Godara et al. | Aug 2014 | A1 |
| 20140243943 | Rao et al. | Aug 2014 | A1 |
| 20140257265 | Godara et al. | Sep 2014 | A1 |
| 20140257296 | Morgenstern Lopez | Sep 2014 | A1 |
| 20140271717 | Goshayeshgar et al. | Sep 2014 | A1 |
| 20140275760 | Lee et al. | Sep 2014 | A1 |
| 20140276728 | Goshayeshgar et al. | Sep 2014 | A1 |
| 20140276744 | Arthur et al. | Sep 2014 | A1 |
| 20140288544 | Diederich et al. | Sep 2014 | A1 |
| 20140288546 | Sherman et al. | Sep 2014 | A1 |
| 20140296850 | Condie et al. | Oct 2014 | A1 |
| 20140303610 | McCarthy et al. | Oct 2014 | A1 |
| 20140303614 | McCarthy et al. | Oct 2014 | A1 |
| 20140316405 | Pellegrino et al. | Oct 2014 | A1 |
| 20140316413 | Burger et al. | Oct 2014 | A1 |
| 20140324051 | Pellegrino et al. | Oct 2014 | A1 |
| 20140330332 | Danek et al. | Nov 2014 | A1 |
| 20140336630 | Woloszko et al. | Nov 2014 | A1 |
| 20140336667 | Pellegrino et al. | Nov 2014 | A1 |
| 20140364842 | Werneth et al. | Dec 2014 | A1 |
| 20140371740 | Germain et al. | Dec 2014 | A1 |
| 20150005614 | Heggeness et al. | Jan 2015 | A1 |
| 20150005767 | Werneth et al. | Jan 2015 | A1 |
| 20150045783 | Edidin | Feb 2015 | A1 |
| 20150057658 | Sutton et al. | Feb 2015 | A1 |
| 20150065945 | Zarins et al. | Mar 2015 | A1 |
| 20150073515 | Turovskly et al. | Mar 2015 | A1 |
| 20150105701 | Mayer et al. | Apr 2015 | A1 |
| 20150141876 | Diederich et al. | May 2015 | A1 |
| 20150157402 | Kunis et al. | Jun 2015 | A1 |
| 20150164546 | Pellegrino et al. | Jun 2015 | A1 |
| 20150196358 | Goshayeshgar | Jul 2015 | A1 |
| 20150216588 | Deem et al. | Aug 2015 | A1 |
| 20150231417 | Metcalf et al. | Aug 2015 | A1 |
| 20150272655 | Condie et al. | Oct 2015 | A1 |
| 20150273208 | Hamilton | Oct 2015 | A1 |
| 20150297246 | Patel et al. | Oct 2015 | A1 |
| 20150297282 | Cadouri | Oct 2015 | A1 |
| 20150320480 | Cosman, Jr. et al. | Nov 2015 | A1 |
| 20150335349 | Pellegrino et al. | Nov 2015 | A1 |
| 20150335382 | Pellegrino et al. | Nov 2015 | A1 |
| 20150342619 | Weitzman | Dec 2015 | A1 |
| 20150342660 | Nash | Dec 2015 | A1 |
| 20150342670 | Pellegrino et al. | Dec 2015 | A1 |
| 20150359586 | Heggeness | Dec 2015 | A1 |
| 20150374432 | Godara et al. | Dec 2015 | A1 |
| 20150374992 | Crosby et al. | Dec 2015 | A1 |
| 20150374995 | Foreman et al. | Dec 2015 | A1 |
| 20160000601 | Burger et al. | Jan 2016 | A1 |
| 20160001096 | Mishelevich | Jan 2016 | A1 |
| 20160002627 | Bennett et al. | Jan 2016 | A1 |
| 20160008593 | Cairns | Jan 2016 | A1 |
| 20160008618 | Omar-Pasha | Jan 2016 | A1 |
| 20160008628 | Morries et al. | Jan 2016 | A1 |
| 20160016012 | Youn et al. | Jan 2016 | A1 |
| 20160022988 | Thieme et al. | Jan 2016 | A1 |
| 20160022994 | Moffitt et al. | Jan 2016 | A1 |
| 20160024208 | MacDonald et al. | Jan 2016 | A1 |
| 20160029930 | Plumley et al. | Feb 2016 | A1 |
| 20160030276 | Spanyer | Feb 2016 | A1 |
| 20160030408 | Levin | Feb 2016 | A1 |
| 20160030748 | Edgerton et al. | Feb 2016 | A1 |
| 20160030765 | Towne et al. | Feb 2016 | A1 |
| 20160045207 | Kovacs et al. | Feb 2016 | A1 |
| 20160045256 | Godara et al. | Feb 2016 | A1 |
| 20160051831 | Landmark et al. | Feb 2016 | A1 |
| 20160059007 | Koop | Mar 2016 | A1 |
| 20160074068 | Patwardhan | Mar 2016 | A1 |
| 20160074133 | Shikhman et al. | Mar 2016 | A1 |
| 20160074279 | Shin | Mar 2016 | A1 |
| 20160074661 | Lipani | Mar 2016 | A1 |
| 20160081716 | Boling et al. | Mar 2016 | A1 |
| 20160081810 | Reiiey et al. | Mar 2016 | A1 |
| 20160095721 | Schell et al. | Apr 2016 | A1 |
| 20160106443 | Kuntz et al. | Apr 2016 | A1 |
| 20160106985 | Zhu | Apr 2016 | A1 |
| 20160106994 | Crosby et al. | Apr 2016 | A1 |
| 20160113704 | Godara et al. | Apr 2016 | A1 |
| 20160115173 | Bois et al. | Apr 2016 | A1 |
| 20160136310 | Bradford et al. | May 2016 | A1 |
| 20160144182 | Bennett et al. | May 2016 | A1 |
| 20160144187 | Caparso et al. | May 2016 | A1 |
| 20160158551 | Kent et al. | Jun 2016 | A1 |
| 20160166302 | Tan-Maiecki et al. | Jun 2016 | A1 |
| 20160166835 | De Ridder | Jun 2016 | A1 |
| 20160175586 | Edgerton et al. | Jun 2016 | A1 |
| 20160199097 | Linderman et al. | Jul 2016 | A1 |
| 20160199117 | Druma | Jul 2016 | A1 |
| 20160213927 | McGee et al. | Jul 2016 | A1 |
| 20160220317 | Shikhman et al. | Aug 2016 | A1 |
| 20160220393 | Slivka et al. | Aug 2016 | A1 |
| 20160220638 | Dony et al. | Aug 2016 | A1 |
| 20160220672 | Chalasani et al. | Aug 2016 | A1 |
| 20160228131 | Brockman et al. | Aug 2016 | A1 |
| 20160228696 | Imran et al. | Aug 2016 | A1 |
| 20160235471 | Godara et al. | Aug 2016 | A1 |
| 20160235474 | Prisco et al. | Aug 2016 | A1 |
| 20160243353 | Ahmed | Aug 2016 | A1 |
| 20160246944 | Jain et al. | Aug 2016 | A1 |
| 20160250469 | Kim et al. | Sep 2016 | A1 |
| 20160250472 | Carbunaru | Sep 2016 | A1 |
| 20160262830 | Werneth et al. | Sep 2016 | A1 |
| 20160262904 | Schaller et al. | Sep 2016 | A1 |
| 20160271405 | Angara et al. | Sep 2016 | A1 |
| 20160278791 | Pellegrino et al. | Sep 2016 | A1 |
| 20160278846 | Harrison et al. | Sep 2016 | A1 |
| 20160278861 | Ko | Sep 2016 | A1 |
| 20160279190 | Watts et al. | Sep 2016 | A1 |
| 20160279408 | Grigsby et al. | Sep 2016 | A1 |
| 20160279411 | Rooney et al. | Sep 2016 | A1 |
| 20160279441 | Imran | Sep 2016 | A1 |
| 20160302925 | Keogh et al. | Oct 2016 | A1 |
| 20160302936 | Billon et al. | Oct 2016 | A1 |
| 20160310739 | Burdick et al. | Oct 2016 | A1 |
| 20160317053 | Srivastava | Nov 2016 | A1 |
| 20160317211 | Harrison et al. | Nov 2016 | A1 |
| 20160317621 | Bright | Nov 2016 | A1 |
| 20160324541 | Pellegrino et al. | Nov 2016 | A1 |
| 20160324677 | Hyde et al. | Nov 2016 | A1 |
| 20160325100 | Lian et al. | Nov 2016 | A1 |
| 20160339251 | Kent et al. | Nov 2016 | A1 |
| 20160354093 | Pellegrino et al. | Dec 2016 | A1 |
| 20160354233 | Sansone et al. | Dec 2016 | A1 |
| 20160367797 | Eckermann | Dec 2016 | A1 |
| 20160367823 | Cowan et al. | Dec 2016 | A1 |
| 20160375259 | Davis et al. | Dec 2016 | A1 |
| 20170000501 | Aho et al. | Jan 2017 | A1 |
| 20170001026 | Schwarz et al. | Jan 2017 | A1 |
| 20170007277 | Drapeau et al. | Jan 2017 | A1 |
| 20170014169 | Dean et al. | Jan 2017 | A1 |
| 20170027618 | Lee et al. | Feb 2017 | A1 |
| 20170028198 | Degiorgio et al. | Feb 2017 | A1 |
| 20170028201 | Howard | Feb 2017 | A1 |
| 20170035483 | Crainich et al. | Feb 2017 | A1 |
| 20170036009 | Hughes et al. | Feb 2017 | A1 |
| 20170036025 | Sachs et al. | Feb 2017 | A1 |
| 20170036033 | Perryman et al. | Feb 2017 | A9 |
| 20170042834 | Westphal et al. | Feb 2017 | A1 |
| 20170049500 | Shikhman et al. | Feb 2017 | A1 |
| 20170049503 | Cosman | Feb 2017 | A1 |
| 20170049507 | Cosman | Feb 2017 | A1 |
| 20170049513 | Cosman | Feb 2017 | A1 |
| 20170050017 | Cosman | Feb 2017 | A1 |
| 20170050021 | Cosman | Feb 2017 | A1 |
| 20170050024 | Bhadra et al. | Feb 2017 | A1 |
| 20170056028 | Germain et al. | Mar 2017 | A1 |
| 20170065329 | Benamou et al. | Mar 2017 | A1 |
| 20170112507 | Crainich et al. | Apr 2017 | A1 |
| 20170128080 | Torrie | May 2017 | A1 |
| 20170128112 | Germain | May 2017 | A1 |
| 20170135742 | Lee et al. | May 2017 | A1 |
| 20170199461 | Godara et al. | May 2017 | A1 |
| 20170164998 | Klimovitch | Jun 2017 | A1 |
| 20170172650 | Germain | Jun 2017 | A1 |
| 20170181788 | Dastjerdi et al. | Jun 2017 | A1 |
| 20170202613 | Pellegrino et al. | Jul 2017 | A1 |
| 20170238943 | Sennett et al. | Aug 2017 | A1 |
| 20170246481 | Mishelevich | Aug 2017 | A1 |
| 20170266419 | Goshayeshgar | Sep 2017 | A1 |
| 20170303983 | Linderman et al. | Oct 2017 | A1 |
| 20170312007 | Harlev et al. | Nov 2017 | A1 |
| 20170333052 | Ding et al. | Nov 2017 | A1 |
| 20180021048 | Pellegrino et al. | Jan 2018 | A1 |
| 20180042656 | Edidin | Feb 2018 | A1 |
| 20180055539 | Pellegrino | Mar 2018 | A1 |
| 20180103964 | Patel et al. | Apr 2018 | A1 |
| 20180140245 | Videman | May 2018 | A1 |
| 20180153604 | Ayvazyan et al. | Jun 2018 | A1 |
| 20180161047 | Purdy et al. | Jun 2018 | A1 |
| 20180193088 | Sutton et al. | Jul 2018 | A1 |
| 20190029698 | Pellegrino et al. | Jan 2019 | A1 |
| 20190038296 | Pellegrino | Feb 2019 | A1 |
| 20190038343 | Sutton et al. | Feb 2019 | A1 |
| 20190038344 | Pellegrino | Feb 2019 | A1 |
| 20190038345 | Pellegrino | Feb 2019 | A1 |
| 20190090933 | Pellegrino et al. | Mar 2019 | A1 |
| 20190110833 | Pellegrino et al. | Apr 2019 | A1 |
| 20190118003 | Diederich et al. | Apr 2019 | A1 |
| 20190118004 | Diederich et al. | Apr 2019 | A1 |
| 20190118005 | Diederich et al. | Apr 2019 | A1 |
| 20190175252 | Heggeness | Jun 2019 | A1 |
| 20190282268 | Pellegrino et al. | Sep 2019 | A1 |
| 20190290296 | Patel et al. | Sep 2019 | A1 |
| 20190298392 | Capote et al. | Oct 2019 | A1 |
| 20190365416 | Brockman et al. | Dec 2019 | A1 |
| 20200000480 | Alambeigi et al. | Jan 2020 | A1 |
| 20200022709 | Burger et al. | Jan 2020 | A1 |
| 20200030601 | Molnar et al. | Jan 2020 | A1 |
| 20200060695 | Purdy et al. | Feb 2020 | A1 |
| 20200060747 | Edidin | Feb 2020 | A1 |
| 20200069920 | Goshayeshgar | Mar 2020 | A1 |
| 20200078083 | Sprinkle et al. | Mar 2020 | A1 |
| 20200138454 | Patel et al. | May 2020 | A1 |
| 20200146743 | Defosset et al. | May 2020 | A1 |
| 20200146744 | Defosset et al. | May 2020 | A1 |
| 20200214762 | Pellegrino et al. | Jul 2020 | A1 |
| 20200281646 | Pellegrino et al. | Sep 2020 | A1 |
| 20210022814 | Crawford et al. | Jan 2021 | A1 |
| 20210113238 | Donovan et al. | Apr 2021 | A1 |
| 20210177502 | Wright et al. | Jun 2021 | A1 |
| 20210361350 | Pellegrino | Nov 2021 | A1 |
| 20210361351 | Pellegrino et al. | Nov 2021 | A1 |
| 20210369323 | Edidin | Dec 2021 | A1 |
| 20210386491 | Shmayahu et al. | Dec 2021 | A1 |
| 20220015775 | Patel et al. | Jan 2022 | A1 |
| 20220192702 | Donovan et al. | Jun 2022 | A1 |
| Number | Date | Country |
|---|---|---|
| 2012244378 | May 2015 | AU |
| 0040658 | Dec 1981 | EP |
| 0584959 | Mar 1994 | EP |
| 0597463 | May 1994 | EP |
| 0880938 | Dec 1998 | EP |
| 1013228 | Jun 2000 | EP |
| 1059067 | Dec 2000 | EP |
| 1059087 | Dec 2000 | EP |
| 1294323 | Apr 2007 | EP |
| 1938765 | Jul 2008 | EP |
| 1471836 | Apr 2010 | EP |
| 2785260 | Aug 2015 | EP |
| 2965782 | Jan 2016 | EP |
| 2205313 | Nov 2016 | EP |
| 53-139791 | Nov 1978 | JP |
| 60-016764 | Feb 1985 | JP |
| 06-47058 | Feb 1994 | JP |
| 10-290806 | Nov 1998 | JP |
| 2001-037760 | Feb 2001 | JP |
| 2005-169012 | Jun 2005 | JP |
| WO 9636289 | Nov 1996 | WO |
| WO 9827876 | Jul 1998 | WO |
| WO 9834550 | Aug 1998 | WO |
| WO 9919025 | Apr 1999 | WO |
| WO 9944519 | Sep 1999 | WO |
| WO 9948621 | Sep 1999 | WO |
| WO 0021448 | Apr 2000 | WO |
| WO 0033909 | Jun 2000 | WO |
| WO 0049978 | Aug 2000 | WO |
| WO 0056237 | Sep 2000 | WO |
| WO 0067648 | Nov 2000 | WO |
| WO 0067656 | Nov 2000 | WO |
| WO 0101877 | Jan 2001 | WO |
| WO 0145579 | Jun 2001 | WO |
| WO 0157655 | Aug 2001 | WO |
| WO 0205699 | Jan 2002 | WO |
| WO 0205897 | Jan 2002 | WO |
| WO 0228302 | Apr 2002 | WO |
| WO 2002026319 | Apr 2002 | WO |
| WO 02054941 | Jul 2002 | WO |
| WO 02067797 | Sep 2002 | WO |
| WO 02096304 | Dec 2002 | WO |
| WO 0731264 | Mar 2007 | WO |
| WO 08001385 | Jan 2008 | WO |
| WO 08008522 | Jan 2008 | WO |
| WO 2008076330 | Jun 2008 | WO |
| WO 2008076357 | Jun 2008 | WO |
| WO 08121259 | Oct 2008 | WO |
| WO08121259 | Oct 2008 | WO |
| WO 2008140519 | Nov 2008 | WO |
| WO 2008144709 | Nov 2008 | WO |
| WO 2009076461 | Jun 2009 | WO |
| WO 2009124192 | Oct 2009 | WO |
| WO 2009155319 | Dec 2009 | WO |
| WO 2010036865 | Apr 2010 | WO |
| WO 2010111246 | Sep 2010 | WO |
| WO 2010135606 | Nov 2010 | WO |
| WO 2011041038 | Apr 2011 | WO |
| WO 2012024162 | Feb 2012 | WO |
| WO 2012074932 | Jun 2012 | WO |
| WO 2013009516 | Jan 2013 | WO |
| WO2013134452 | Sep 2013 | WO |
| WO 2013180947 | Dec 2013 | WO |
| WO 2014004051 | Jan 2014 | WO |
| WO 2014130231 | Aug 2014 | WO |
| WO 2014141207 | Sep 2014 | WO |
| WO 2014165194 | Oct 2014 | WO |
| WO 2014176141 | Oct 2014 | WO |
| WO 2015038317 | Mar 2015 | WO |
| WO 2016105448 | Jun 2016 | WO |
| WO 2016105449 | Jun 2016 | WO |
| WO 2017027809 | Feb 2017 | WO |
| WO 2018116273 | Jun 2018 | WO |
| WO 2020198150 | Oct 2020 | WO |
| Entry |
|---|
| Caragee, EG et al.; “Discographic, MRI and psychosocial determinants of low back pain disability and remission: A prospective study in subjects with benign persistent back pain”, The Spine Journal: The Official Journal of the North American Soine Society, vol. 5(1), pp. 24-35 (2005). |
| Fields, AJ et al; “Innervation of pathologies in the lumbar vertebral endplate and intervertebral disc”, The Spine Journal: Official Journal of the North American Spine Society, vol. 14(3), pp. 513-521 (2014). |
| Fields, Aaron J. et al.; “Cartilage endplate damage strongly associates with chronic low back pain, independent of modic changes”, Abstract form Oral Presentation at the ISSLS Annual Meeting in Banff, Canada (May 14-18, 2018). |
| Fischgrund JS, et al.; “Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain: 2-Year Results from a Prospective Randomized Double-Blind Sham-Controlled Multicenter Study”, International Journal of Spine Surgery, vol. 13 (2), pp. 110-119 (2019). |
| Gehl J. “Electroporation: theory and methods perspectives for drug delivery gene therapy and research” Acta Physiol. Scand. vol. 177 pp. 437-447 (2003). |
| Gornet, Matthew G et al.; “Magnetic resonance spectroscopy (MRS) can identify painful lumbar discs and may facilitate improved clinical outcomes of lumbar surgeries for discogenic pain”, European Spine Journal, vol. 28, pp. 674-687 (2019). |
| Jourabchi, Natanel et al.; “Irreversible electroporation (NanoKnife) in cancer treatment,” Gastrointestinal Intervention, vol. 3, pp. 8-18 (2014). |
| Khalil, J et al.; “A Prospective, Randomized, Multi-Center Study of Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain”, The Spine Journal (2019), available at https://doi.org/10.1016/jspinee.2019.05.598. |
| Kuisma M et al.; “Modic changes in endplates of lumbar vertebral bodies: Prevalence and association with low back and sciatic pain among middle-aged male workers”, Spine, vol. 32(10), pp. 1116-1122 (2007). |
| Lotz JC, et al.; “The Role of the Vertebral End Plate in Low Back Pain”, Global Spine Journal, vol. 3, pp. 153-164 (2013). |
| Modic MT et al.; “Degenerative disk disease: assessment of changes in vertebral body marrow with MR imaging” Radiology vol. 166 pp. 193-199 (1988). |
| Mok, Florence et al.; “Modic changes of the lumbar spine: Prevalence, risk factors, and association with disc degeneration and low back pain in a large-scale population-based cohort”, The Spine Journal: Official Journal of the North American Spine Society, vol. 16(1), pp. 32-41 (2016). |
| Pang, Henry et al.; The UTE Disc Sign on MRI: A Novel Imaging Biomarker Associated With Degenerative Spine Changes, Low Back Pain, and Disability, Spine, vol. 42 (Aug. 2017). |
| Radiological Society of North America. “Pulsed radiofrequency relieves acute back pain and sciatica.” ScienceDaily. ScienceDaily, Nov. 27, 2018. <www.sciencedaily.com/releases/2018/11/181127092604.htm>. |
| YouTube Video, “DFINE-STAR Procedure Animation,” dated Sep. 30, 2013, can be viewed at https://www.youtube.com/watch?v=YxtKNyc2e-0. |
| Weishaupt, D et al,; “Painful Lumbar Disk Derangement: Relevance of Endplate Abnormalities at MR Imaging”, Radiology, vol. 218(2), pp. 420-427 (2001). |
| Kim et al., Transforaminal epiduroscopic basivertebral nerve laser ablation for chronic low back pain associated with modic changes: A preliminary open-label study. Pain Research and Management 2018; https://pubmed.ncbi.nlm.nih.gov/30186540. |
| Rahme et al., The modic vertebral endplate and marrow changes: pathologic significance and relation to low back oain and segmental instability of the lumbar spine. American Journal of Neuroradiology 29.5 (2008): 838-842; http://www.ajnr.org/content/29/5/838. |
| A Novel Approach for Treating Chronic Lower Back Pain, Abstract for Presentation at North American Spine Society 26th Annual Meeting in Chicago, IL on Nov. 4, 2011. |
| Antonacci, M. Darryl et al.; Innervation of the Human Vertebral Body: A Histologic Study; Journal of Spinal Disorder, vol. 11, No. 6, pp. 526-531, 1998 Lippincott Williams & Wilkins, Philadelphia. |
| Arnoldi, Carl C.; Intraosseous Hypertension—A Possible Cause of Low Back Pain?; Clinical Orthopedics and Related Research, No. 115, Mar.-Apr. 1976. |
| Bailey, Jeannie F., “Innervation Patterns of PGP 9.5-Positive Nerve Fibers within the Human Lumbar Vertebra, Journal of Anatomy”, (2011) 218, pp. 263-270, San Francisco, California. |
| Becker, Stephan, et al., “Ablation of the basivertebral nerve for treatment of back pain: a clinical study,” The Spine Journal, vol. 17, pp. 218-223 (Feb. 2017). |
| Bergeron et al., “Fluoroscopic-guided radiofrequency ablation of the basivertebral nerve: application and analysis with multiple imaging modalities in an ovine model,” Thermal Treatment of Tissue: Energy Delivery and Assessment III, edited by Thomas P. Ryan, Proceedings of SPIE, vol. 5698 (SPIE, Bellingham, WA, 2005) pp. 156-167. |
| Bogduk, N. The anatomy of the lumbar intervertebral disc syndrome, Med J. Aust. 1976, vol. 1, No. 23, pp. 878-881. |
| Bogduk, Nikolai, et al.; Technical Limitations to the efficacy of Radiofrequency Neurotomy for Spinal Pain; Neurosurgery vol. 20, No. 4, 1987. |
| Choy, Daniel SS.J. et al.; Percutaneous Laser Disc Decompression, a New Therapeutic Modality; Spine vol. 17, No. 8, 1992. |
| Cosman, E.R. et al., Theoretical Aspects of Radiofrequency Lesions in the Dorsal Root Entry Zone. Neurosurgery, vol. 1, No. 6, 1984, pp. 945-950. |
| Deardorff, Dana L. et al.; Ultrasound applicators with internal cooling for interstitial thermal therapy; SPIE vol. 3594, 1999. |
| Deramond, H. et al., Temperature Elevation Caused by Bone Cement Polymerization During Vertebroplasty, Bone, Aug. 1999, pp. 17S-21S, vol. 25, No. 2, Supplement. |
| Diederich, C. J. et al., “IDTT Therapy in Cadaveric Lumbar Spine: Temperature and thermal dose distributions, Thermal Treatment of Tissue: Energy Delivery and Assessment,” Thomas P. Ryan, Editor, Proceedings of SPIE vol. 4247:104-108 (2001). |
| Diederich, Chris J. et al.; Ultrasound Catheters for Circumferential Cardiac Ablation; SPIE vol. 3594 (1999). |
| Dupuy, D.E. et al. Radiofrequency ablation of spinal tumors: Temperature distribution in the spinal canal AJR, vol. 175, pp. 1263-1266, Nov. 2000. |
| Dupuy, Damian E.; Radiofrequency Ablation: An Outpatient Percutaneous Treatment; Medicine and Health/Rhode Island vol. 82, No. 6, Jun. 1999. |
| Esses, Stephen I. et al.; Intraosseous Vertebral Body Pressures; Spine vol. 17 No. 6 Supplement 1992. |
| FDA Response to 510(k) Submission by Relievant Medsystems, Inc. submitted on Sep. 27, 2007 (date stamped on Oct. 5, 2007) and associated documents. |
| Fras M.D., Christian et al., “Substance P-containing Nerves within the Human Vertebral Body: An Immunohistochemical Study of the Basivertebral Nerve”, The Spine Journal 3, 2003, pp. 63-67. |
| Goldberg, S.N. et al., Tissue ablation with radiofrequency: Effect of probe size, gauge, duration, and temperature on lesion volume, Acad. Radiol., vol. 2, pp. 399-404 (1995). |
| Hanai, Kenji et al.; Simultaneous Measurement of Intraosseous and Cerebrospinal Fluid Pressures in the Lumbar Region; Spine vol. 10, No. 1, 1985. |
| Heggeness, M. et al Ablation of the Basivertebral Nerve forthe Treatment, of Back Pain: A Pilot Clinical Study; The Spine Journal, 2011, vol. 11. Issue 10, Supplement, pp. S65-Sa66, ISSN 1529-9430. |
| Heggeness, Michael H. et al., The Trabecular Anatomy of Thoracolumbar Vertebrae: Implications for Burst Fractures, Journal of Anatomy, 1997, pp. 309-312, vol. 191, Great Britain. |
| Heggeness, Michael H. et al. Discography Causes End Plate Deflection; Spine vol. 18, No. 8, pp. 1050-1053, 1993, J.B. Lippincott Company. |
| Hoopes et al., “Radiofrequency Ablation of the Basivertebral Nerve as a Potential Treatment of Back Pain: Pathologic Assessment in an Ovine Model,” Thermal Treatment of Tissue: Energy Delivery and Assessment III, edited by Thomas P. Ryan, Proceedings of SPIE, vol. 5698 (SPIE, Bellingham, WA, 2005) pp. 168-180. |
| Houpt, Jonathan C. et al.; Experimental Study of Temperature Distributions and Thermal Transport During Radiofrequency Current Therapy of the Intervertebral Disc; Spine vol. 21, No. 15, 1808-1813, 1996, Lippincott-Raven Publishers. |
| Kleinstueck, Frank S. et al.; Acute Biomechanical and Histological Effects of Intradiscal Electrothermal Therapy on Human Lumbar Discs; Spine vol. 26, No. 20, pp. 2198-2207; 2001, Lippincott Williams & Wilkins, Inc. |
| Kopecky, Kenyon K et al. “Side-Exiting Coaxial Needle for Aspiration Biopsy”—AJR—1996; 167, pp. 661-662. |
| Lehmann, Justus F. et al.; Selective Heating Effects of Ultrasound in Human Beings; Archives of Physical Medicine & Rehabilitation Jun. 1966. |
| Letcher, Frank S. et al.; The Effect of Radiofrequency Current and Heat on Peripheral Nerve Action Potential in the Cat; U.S. Naval Hospital, Philadelphia, PA. |
| Lundskog, Jan; Heat and Bone Tissue—/an experimental investigation of the thermal properties of bone tissue and threshold levels for thermal injury; Scandinavian Journal of Plastic and Reconstructive Surgery Supplemental 9, From the Laboratory of Experimental Biology, Department of anatomy, University of Gothenburg, Gothenburg, Sweden, Goteborg 1972. |
| Martin, J.B. et al., Vertebroplasty: Clinical Experience and Follow-up Results, Bone, Aug. 1999, pp. 11S-15S, vol. 25, No. 2, Supplement. |
| Massad, Malek M.D. et al.; Endoscopic Thoracic Sympathectomy: Evaluation of Pulsatile Laser, Non-Pulsatile Laser, and Radiofrequency-Generated Thermocoagulation; Lasers in Surgery and Medicine; 1991; pp. 18-25. |
| Mehta, Mark et al.; The treatment of chronic back pain; Anaesthesia, 1979, vol. 34, pp. 768-775. |
| Nau, Wiliam H., Ultrasound interstitial thermal therapy (USITT) in the prostate; SPIE vol. 3594. |
| Osteocool Pain Management Brochure, Baylis Medical, copyright 2011. |
| Rashbaum, Ralph F.; Radiofrequency Facet Denervation a Treatment alternative in Refractory Low Back Pain with or without Leg Pain; Orthopedic Clinics of North America—vol. 14, No. 3, Jul. 1983. |
| Rosenthal, D.I., Seminars in Musculoskeletal Radiology, vol. 1, No. 2., pp. 265-272 (1997). |
| Ryan et al., “Three-Dimensional Finite Element Simulations of Vertebral Body Thermal Treatment,” Thermal Treatment of Tissue: Energy Delivery and Assessment III, edited by Thomas P. Ryan, Proceedings of SPIE, vol. 5698 (SPIE, Bellingham, WA, 2005) pp. 137-155. |
| Shealy, C. Norman; Percutaneous radiofrequency denervation of spinal facets Treatment for chronic back pain and sciatica; Journal of Neurosurgery/vol. 43/Oct. 1975. |
| Sherman, Mary S.; The Nerves of Bone, The Journal of Bone and Joint Surgery, Apr. 1963, pp. 522-528, vol. 45-A, No. 3. |
| Solbiati, L. et al. Hepatic metastases: Percutaneous radio-frequency ablation with cooled-tip electrodes. Interventional Radiology, vol. 205, No. 2, pp. 367-373 (1997). |
| Stanton, Terry, “Can Nerve Ablation Reduce Chronic Back Pain ?” AAOS Now Jan. 2012. |
| The AVAmax System—Cardinal Health Special Procedures, Lit. No. 25P0459-01—www.cardinal.com (copyright 2007). |
| Tillotson, L. et al. Controlled thermal injury of bone: Report of a percutaneous technique using radiofrequency electrode and generator. Investigative Radiology, Nov. 1989, pp. 888-892. |
| Troussier, B. et al.; Percutaneous Intradiscal Radio-Frequency Thermocoagulation a Cadaveric Study; Spine vol. 20, No. 15, pp. 1713-1718, 1995, Lippincott-Raven Publishers. |
| Ullrich, Jr. Peter F., “Lumbar Spinal Fusion Surgery” Jan. 9, 2013, Spine-Health (available via wayback machine Internet archive at http://web.archive.org/web/20130109095419/http://www/spine-health.come/treatement/spinal-fusion/lumbar-spinal-fusion-surgery. |
| Macadaeg et al, A prospective single arm study of intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: 12-month results. North American Spine Society Journal; May 27, 2020, 8 pages. |
| Vadala et al., “Robotic Spine Surgery and Augmented Reality Systems: A State of the Art”, Neurospine Epub Mar. 31, 2020; revised: Feb. 22, 2020; acepted: Feb. 24, 2020; retrieved on [Oct. 6, 2022]. Retrieved from the internet URL:https://www.ncbi.nim.nih.gov/pmc/articies/PMC7136092/pdf/ns-2040060-030.pdf entire document. |
| Number | Date | Country | |
|---|---|---|---|
| 20190090933 A1 | Mar 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61582170 | Dec 2011 | US | |
| 61582165 | Dec 2011 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 14369661 | US | |
| Child | 16205050 | US |
